<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="cfeom" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">cfeom</book-part-id>
      <title-group>
        <title>Congenital Fibrosis of the Extraocular Muscles</title>
        <alt-title alt-title-type="alt-title">Synonym: CFEOM</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Whitman</surname>
            <given-names>Mary</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Department of Ophthalmology, Boston Children's Hospital<break/>Instructor in Ophthalmology, Harvard Medical School<break/>Boston, Massachusetts</aff>
          <email>mary.whitman@childrens.harvard.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hunter</surname>
            <given-names>David G</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Ophthalmologist-in-Chief, Boston Children's Hospital <break/>Professor of Ophthalmology, Harvard Medical School <break/>Boston, Massachusetts</aff>
          <email>david.hunter@childrens.harvard.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Engle</surname>
            <given-names>Elizabeth C</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Neurology<break/>Children's Hospital Boston<break/>Professor of Neurology and Ophthalmology, Harvard Medical School <break/>Boston, Massachusetts<break/>Howard Hughes Medical Institute<break/>Chevy Chase, Maryland</aff>
          <email>elizabeth.engle@childrens.harvard.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>27</day>
          <month>4</month>
          <year>2004</year>
        </date>
        <date date-type="updated">
          <day>14</day>
          <month>1</month>
          <year>2016</year>
        </date>
        <date date-type="revised">
          <day>29</day>
          <month>12</month>
          <year>2011</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="cftd" document-type="chapter">Congenital Fiber-Type Disproportion</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="hepatic-fibrosis" document-type="chapter">Congenital Hepatic Fibrosis Overview</related-object>
      <abstract id="cfeom.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Congenital fibrosis of the extraocular muscles (CFEOM) refers to at least eight genetically defined strabismus syndromes (CFEOM1A, CFEOM1B, CFEOM2, CFEOM3A, CFEOM3B, CFEOM3C, Tukel syndrome, and CFEOM3 with polymicrogyria) characterized by congenital non-progressive ophthalmoplegia (inability to move the eyes) with or without ptosis (droopy eyelids) affecting part or all of the oculomotor nucleus and nerve (cranial nerve III) and its innervated muscles (superior, medial, and inferior recti, inferior oblique, and levator palpabrae superioris) and/or the trochlear nucleus and nerve (cranial nerve IV) and its innervated muscle (the superior oblique). In general, affected individuals have severe limitation of vertical gaze (usually upgaze) and variable limitation of horizontal gaze. Individuals with CFEOM frequently compensate for the ophthalmoplegia by maintaining abnormal head positions at rest and by moving their heads rather than their eyes to track objects. Individuals with CFEOM3A may also have intellectual disability, social disability, Kallmann syndrome, facial weakness, and vocal cord paralysis; and/or may develop a progressive sensorimotor axonal polyneuropathy. Individuals with Tukel syndrome also have postaxial oligodactyly or oligosyndactyly of the hands. Those with CFEOM3 with polymicrogyria also have microcephaly and intellectual disability.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of CFEOM is based on ophthalmologic findings, and the subtypes depend on the identification of specific eye findings and associated findings. <italic toggle="yes">KIF21A</italic> pathogenic variants are associated with CFEOM1A and CFEOM3B. <italic toggle="yes">PHOX2A</italic> pathogenic variants are associated with CFEOM2. <italic toggle="yes">TUBB3</italic> pathogenic variants are associated with CFEOM3A and CFEOM1B. <italic toggle="yes">TUBB2B</italic> pathogenic variants are associated with CFEOM3A and CFEOM3 with polymicrogyria.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Refractive errors may be managed with glasses or contact lenses. Amblyopia can be treated effectively with occlusion or penalization of the better-seeing eye. Corneal lubrication may be helpful. Corrective eye muscle and/or ptosis surgery may be required.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Amblyopia therapy to prevent vision loss in the less-preferred eye.</p>
          <p><italic toggle="yes">Surveillance:</italic> To prevent and treat amblyopia and to address complications of corneal exposure: routine ophthalmologic care with visits every three to four months during the first years of life, and annual or biannual examinations in older affected individuals not at risk for amblyopia. In individuals with specific <italic toggle="yes">TUBB3</italic> variants, surveillance for endocrine abnormalities, facial or vocal cord weakness, and interventions for developmental delays are indicated.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Early clinical diagnosis can lead to early treatment and prevention of secondary complications.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>CFEOM is inherited in either an autosomal dominant (CFEOM1, CFEOM3, and CFEOM3 with polymicrogyria) or autosomal recessive (CFEOM2 and Tukel syndrome) manner.</p>
          <list list-type="bullet">
            <list-item>
              <p>CFEOM1, CFEOM3, and CFEOM3 with polymicrogyria. An affected individual may have inherited a pathogenic variant from an affected parent or have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. Each child of an individual with autosomal dominant CFEOM has a 50% chance of inheriting the pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>CFEOM2 and Tukel syndrome. The parents of a child with autosomal recessive CFEOM are obligate heterozygotes (i.e., carriers of one pathogenic variant). At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
          </list>
          <p>Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant(s) have been identified in an affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="cfeom.Diagnosis">
        <title>Diagnosis</title>
        <p>The term congenital fibrosis of the extraocular muscles (CFEOM) refers to several syndromes: CFEOM1A, CFEOM1B, CFEOM2, CFEOM3A, CFEOM3B, CFEOM3C, Tukel syndrome, and CFEOM3 with polymicrogyria [<xref ref-type="bibr" rid="cfeom.REF.doherty.1999.1687">Doherty et al 1999</xref>, <xref ref-type="bibr" rid="cfeom.REF.nakano.2001.315">Nakano et al 2001</xref>, <xref ref-type="bibr" rid="cfeom.REF.yamada.2003.318">Yamada et al 2003</xref>, <xref ref-type="bibr" rid="cfeom.REF.aubourg.2005.253">Aubourg et al 2005</xref>, <xref ref-type="bibr" rid="cfeom.REF.tukel.2005.408">Tukel et al 2005</xref>, <xref ref-type="bibr" rid="cfeom.REF.karadeniz.2009.e570">Karadeniz et al 2009</xref>, <xref ref-type="bibr" rid="cfeom.REF.khan.2010.154">Khan et al 2010</xref>, <xref ref-type="bibr" rid="cfeom.REF.tischfield.2010.74">Tischfield et al 2010</xref>, <xref ref-type="bibr" rid="cfeom.REF.cederquist.2012.5484">Cederquist et al 2012</xref>].</p>
        <sec id="cfeom.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Congenital fibrosis of the extraocular muscles (CFEOM) <bold>should be suspected</bold> in individuals with the following clinical features:</p>
          <list list-type="bullet">
            <list-item>
              <p>Congenital non-progressive ophthalmoplegia (inability to move the eyes) typically with severe limitation of vertical gaze (usually upgaze) and variable limitation of horizontal gaze</p>
            </list-item>
            <list-item>
              <p>Ptosis (droopy eyelids) that may range from mild to profound, and can be unilateral</p>
            </list-item>
          </list>
          <p>The condition affects part or all of the oculomotor nucleus and nerve (cranial nerve III) and its innervated muscles (superior, medial, and inferior recti, inferior oblique, and levator palpabrae superioris) and/or the trochlear nucleus and nerve (cranial nerve IV) and its innervated muscle (the superior oblique).</p>
          <p>Typically binocular vision is absent. Refractive errors are common.</p>
          <p>Note: For complete description of the eye findings to aid in establishing the diagnosis of a specific form of CFEOM, see <xref ref-type="table" rid="cfeom.T.comparison_of_types_of_cfeom">Table 1</xref>.</p>
          <table-wrap id="cfeom.T.comparison_of_types_of_cfeom" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Comparison of Types of CFEOM</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"/>
                  <th id="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">CFEOM1</th>
                  <th id="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">CFEOM2</th>
                  <th id="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">CFEOM3</th>
                  <th id="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Tukel Syndrome</th>
                  <th id="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">CFEOM3 w/Polymicrogyria</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>External ophthalmo-<break/>plegia</bold>
                  </td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Congenital, non-progressive. bilateral, profound, w/limited upgaze</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Congenital, non-progressive, bilateral, profound, w/eyes in exotropic (outward deviating) position</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Congenital, non-progressive, bilateral OR unilateral; primarily affecting muscles in the oculomotor distribution&#x000a0;<sup>1</sup></td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Congenital, non-progressive, bilateral OR unilateral; primarily affecting muscles in the oculomotor distribution&#x000a0;<sup>1</sup></td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Congenital, non-progressive, bilateral; limited upgaze</td>
                </tr>
                <tr>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Lid position</bold>
                  </td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Congenital non-progressive bilateral ptosis</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Congenital non-progressive bilateral ptosis</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Normal OR congenital non-progressive bilateral or unilateral ptosis</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Normal OR congenital non-progressive bilateral or unilateral ptosis</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Congenital non-progressive bilateral ptosis</td>
                </tr>
                <tr>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Primary vertical position of each eye</bold>
                  </td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Infraducted (downward)</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Normal or positioned slightly above or below midline</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Infraducted or normal (primary position)</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Infraducted or normal (primary position)</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Infraducted</td>
                </tr>
                <tr>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Vertical eye movements</bold>
                  </td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Inability to elevate eyes above horizontal midline</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Severely restricted</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Variable restriction w/ or w/out upgaze above midline</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Variable restriction w/ or w/out upgaze above midline</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Severely limited</td>
                </tr>
                <tr>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Primary horizontal position of each eye</bold>
                  </td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Orthotropic (normal), esotropic (inward), or exotropic (outward)</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Typically exotropic; rarely, orthotropic</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Orthotropic or exotropic more frequent than esotropic</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Orthotropic or exotropic may be more frequent than esotropic</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Orthotropic or exotropic</td>
                </tr>
                <tr>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Horizontal eye movements</bold>
                  </td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Normal to severely restricted</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Severely restricted; only abduction preserved</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Normal to severely restricted</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Normal to severely restricted</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Variably restricted</td>
                </tr>
                <tr>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Aberrant eye movements</bold>
                  </td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Frequent, especially both eyes turning inward on attempted upgaze</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Small amplitude, if present</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sometimes present</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Sometimes present</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Convergent nystagmus w/attempted upgaze</td>
                </tr>
                <tr>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Forced duction test</bold>
                  </td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Positive for restriction</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Positive for restriction</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Positive for restriction at least in attempted upgaze</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Positive for restriction at least in attempted upgaze</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Positive for restriction</td>
                </tr>
                <tr>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Binocular vision</bold>
                  </td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Usually absent</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Absent</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Rarely present</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Rarely present</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Usually absent</td>
                </tr>
                <tr>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Refractive errors</bold>
                  </td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Frequently high astigmatism</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Frequent</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Common</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Common</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Frequent, high astigmatism</td>
                </tr>
                <tr>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Amblyopia</bold>
                  </td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Frequent; may be strabismic or refractive in nature</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Frequent</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Frequent</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Frequent</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Frequent</td>
                </tr>
                <tr>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Pupils</bold>
                  </td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Normal</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Often small &#x00026; sluggishly reactive to light</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Typically normal, occasionally small &#x00026; sluggish</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Normal</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Normal</td>
                </tr>
                <tr>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Family history</bold>
                  </td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Consistent w/AD inheritance; simplex cases&#x000a0;<sup>2</sup> observed; parental germline mosaicism can mimic AR inheritance</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Consistent w/AR inheritance</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Consistent w/AD inheritance; simplex cases&#x000a0;<sup>2</sup> observed; parental germline mosaicism can mimic AR inheritance</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Consistent w/AR inheritance</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Consistent w/AD inheritance</td>
                </tr>
                <tr>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Genetics</bold>
                  </td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">CFEOM1A: associated w/pathogenic variants in <italic toggle="yes">KIF21A</italic><break/>CFEOM1B: associated w/path variants in <italic toggle="yes">TUBB3</italic></td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Associated w/path variants in <italic toggle="yes">PHOX2A</italic></td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">CFEOM3A: associated w/path variants in <italic toggle="yes">TUBB3</italic> or <italic toggle="yes">TUBB2B</italic><break/>CFEOM3B: associated w/path variants in <italic toggle="yes">KIF21A</italic><break/>CFEOM3C: refers to cosegregation of CFEOM3 w/a translocation (in 1 family)</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Associated w/path variants in <italic toggle="yes">TUBB2B</italic></td>
                </tr>
                <tr>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Additional findings</bold>
                  </td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">None</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Retinal dysfunction</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Variably present in CFEOM3A: <break/>intellectual &#x00026; social disability, facial weakness, vocal cord paralysis, Kallmann syndrome, cyclic vomiting, spasticity, progressive sensorimotor axonal polyneuropathy<break/>On brain MRI: <break/>malformations of cortical development; dysgenesis of: corpus callosum, anterior commissure, corticospinal tracts, &#x00026; basal ganglia <break/>On MRI of cranial nerves &#x00026; orbits:<break/>hypoplasia of the oculomotor nerve &#x00026; levator/superior rectus muscles</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Postaxial oligodactyly or oligosyndactyly of the hands;<break/>In one affected person w/an unbalanced translocation: facial dysmorphisms, kyphosis, pectus excavatum, developmental delay, &#x00026; motor regression</td>
                  <td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Intellectual disability,<break/>polymicrogyria,<break/>microcephaly</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>AD = autosomal dominant</p>
              </fn>
              <fn>
                <p>AR = autosomal recessive</p>
              </fn>
              <fn id="cfeom.TF.1.1">
                <label>1. </label>
                <p>In individuals not meeting CFEOM1 criteria</p>
              </fn>
              <fn id="cfeom.TF.1.2">
                <label>2. </label>
                <p>A single occurrence in a family</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="cfeom.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of CFEOM <bold>is established</bold> in a proband with identification of a specific CFEOM phenotype and/or of a heterozygous pathogenic variant in <italic toggle="yes">KIF21A, TUBB3</italic>, or <italic toggle="yes">TUBB2B</italic> or biallelic pathogenic variants in <italic toggle="yes">PHOX2A</italic> by molecular genetic testing (see <xref ref-type="table" rid="cfeom.T.molecular_genetic_testing_used_i">Table 2</xref>).</p>
          <p>Molecular testing approaches can include <bold>serial single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>.</p>
          <p><bold>Serial single-gene testing</bold> can be considered if (1) a pathogenic variant in a particular gene accounts for a large proportion of the disease OR (2) additional factors (e.g., clinical findings, laboratory findings, and ancestry) indicate that a pathogenic variant in a particular gene is most likely. Sequence analysis of the gene of interest is performed first, followed by gene-targeted deletion/duplication analysis if no pathogenic variant is found.</p>
          <list list-type="bullet">
            <list-item>
              <p>For patients with a CFEOM1 phenotype, sequence analysis of <italic toggle="yes">KIF21A</italic>, followed by sequence analysis of <italic toggle="yes">TUBB3</italic> should be performed. All disease-associated alleles reported in <italic toggle="yes">KIF21A</italic> and <italic toggle="yes">TUBB3</italic> have been missense variants; thus, gene-targeted deletion/duplication analysis is not recommended.</p>
            </list-item>
            <list-item>
              <p>For patients with the CFEOM2 phenotype, sequence analysis of <italic toggle="yes">PHOX2A</italic> should be performed, followed by gene-targeted deletion analysis if no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p>For patients with a CFEOM3 phenotype, sequence analysis of <italic toggle="yes">TUBB3</italic> should be performed first, followed by sequence analysis of <italic toggle="yes">KIF21A</italic>. All disease-associated alleles reported in <italic toggle="yes">KIF21A</italic> and <italic toggle="yes">TUBB3</italic> have been missense variants; thus, gene-targeted deletion/duplication analysis is not recommended.</p>
            </list-item>
          </list>
          <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">KIF21A, TUBB3, TUBB2B, PHOX2A,</italic> and other genes of interest (see <xref ref-type="sec" rid="cfeom.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included and the sensitivity of multi-gene panels vary by laboratory and over time.</p>
          <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing, genome sequencing, and mitochondrial sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel that includes <italic toggle="yes">KIF21A, TUBB3, TUBB2B,</italic> and <italic toggle="yes">PHOX2A</italic>) fails to confirm a diagnosis in an individual with features of CFEOM. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
          <table-wrap id="cfeom.T.molecular_genetic_testing_used_i" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Molecular Genetic Testing Used in CFEOM</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_2">Proportion of CFEOM Attributed to Pathogenic Variants in This Gene</th>
                  <th id="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detected by Test Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3" id="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Sequence analysis&#x000a0;<sup>3</sup></th>
                  <th headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3" id="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>4</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">KIF21A</italic>
                  </td>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">~55%</td>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">81/94 in CFEOM1&#x000a0;<sup>5</sup><break/>5/20 in CFEOM3&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">TUBB3</italic>
                  </td>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">~35%</td>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">15/15 in isolated CFEOM3&#x000a0;<sup>8</sup><break/>27/27 in CFEOM3 with additional neurologic findings&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">PHOX2A</italic>
                  </td>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">~10%</td>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">15/15 in CFEOM2&#x000a0;<sup>10</sup></td>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">TUBB2B</italic>
                  </td>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">3/3 in CFEOM3 with polymicrogyria&#x000a0;<sup>11</sup></td>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>12</sup></td>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_1 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_2" valign="middle" colspan="2" align="left" rowspan="1">NA</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="cfeom.TF.2.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="cfeom" object-id="cfeom.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="cfeom.TF.2.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="cfeom.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="cfeom.TF.2.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="cfeom.TF.2.4">
                <label>4. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="cfeom.TF.2.5">
                <label>5. </label>
                <p><xref ref-type="bibr" rid="cfeom.REF.yamada.2003.318">Yamada et al [2003]</xref>, <xref ref-type="bibr" rid="cfeom.REF.ali.2004.247">Ali et al [2004]</xref>, <xref ref-type="bibr" rid="cfeom.REF.tiab.2004.241">Tiab et al [2004]</xref>, <xref ref-type="bibr" rid="cfeom.REF.traboulsi.2004.237">Traboulsi &#x00026; Engle [2004]</xref>, <xref ref-type="bibr" rid="cfeom.REF.lin.2005.245">Lin et al [2005]</xref>, <xref ref-type="bibr" rid="cfeom.REF.shimizu.2005.443">Shimizu et al [2005]</xref>, <xref ref-type="bibr" rid="cfeom.REF.yamada.2005.1254">Yamada et al [2005]</xref>, <xref ref-type="bibr" rid="cfeom.REF.chan.2007.26">Chan et al [2007]</xref>, <xref ref-type="bibr" rid="cfeom.REF.karadeniz.2009.e570">Karadeniz et al [2009]</xref>, <xref ref-type="bibr" rid="cfeom.REF.rudolph.2009.667">Rudolph et al [2009]</xref>, <xref ref-type="bibr" rid="cfeom.REF.yang.2010.2062">Yang et al [2010]</xref>, <xref ref-type="bibr" rid="cfeom.REF.khan.2011.218">Khan et al [2011]</xref>, <xref ref-type="bibr" rid="cfeom.REF.wang.2011.973">Wang et al [2011]</xref>, <xref ref-type="bibr" rid="cfeom.REF.luk.2013.182">Luk et al [2013]</xref>, <xref ref-type="bibr" rid="cfeom.REF.ying.2013.63">Ying et al [2013]</xref>, <xref ref-type="bibr" rid="cfeom.REF.ali.2014.368">Ali et al [2014]</xref>, <xref ref-type="bibr" rid="cfeom.REF.ka_ar_bayram.2015.743">Ka&#x000e7;ar Bayram et al [2015]</xref></p>
              </fn>
              <fn id="cfeom.TF.2.6">
                <label>6. </label>
                <p><xref ref-type="bibr" rid="cfeom.REF.yamada.2004.2218">Yamada et al [2004]</xref>, <xref ref-type="bibr" rid="cfeom.REF.lin.2005.245">Lin et al [2005]</xref>, <xref ref-type="bibr" rid="cfeom.REF.lu.2008.388">Lu et al [2008]</xref>, <xref ref-type="bibr" rid="cfeom.REF.yang.2010.2062">Yang et al [2010]</xref></p>
              </fn>
              <fn id="cfeom.TF.2.7">
                <label>7. </label>
                <p>No data on detection rate of gene-targeted deletion/duplication analysis are available.</p>
              </fn>
              <fn id="cfeom.TF.2.8">
                <label>8. </label>
                <p>Individuals who have the eye phenotype only, with no additional medical conditions. <italic toggle="yes">TUBB3</italic> pathogenic variants are associated with familial and simplex occurrences of CFEOM3 [<xref ref-type="bibr" rid="cfeom.REF.tischfield.2010.74">Tischfield et al 2010</xref>]; this is referred to as CFEOM3A. <italic toggle="yes">TUBB3</italic> pathogenic variants are also a rare cause of CFEOM1; this is referred to as CFEOM1B.</p>
              </fn>
              <fn id="cfeom.TF.2.9">
                <label>9. </label>
                <p><xref ref-type="bibr" rid="cfeom.REF.tischfield.2010.74">Tischfield et al [2010]</xref>, <xref ref-type="bibr" rid="cfeom.REF.chew.2013.522">Chew et al [2013]</xref>, <xref ref-type="bibr" rid="cfeom.REF.mackinnon.2014.1461">MacKinnon et al [2014]</xref>, <xref ref-type="bibr" rid="cfeom.REF.balasubramanian.2015.e473">Balasubramanian et al [2015]</xref>, <xref ref-type="bibr" rid="cfeom.REF.whitman.2016.297">Whitman et al [2016]</xref></p>
              </fn>
              <fn id="cfeom.TF.2.10">
                <label>10. </label>
                <p><xref ref-type="bibr" rid="cfeom.REF.nakano.2001.315">Nakano et al [2001]</xref>, <xref ref-type="bibr" rid="cfeom.REF.yazdani.2003.861">Yazdani et al [2003]</xref>. <italic toggle="yes">PHOX2A</italic> is the only gene in which pathogenic variants are known to cause the CFEOM2 phenotype [<xref ref-type="bibr" rid="cfeom.REF.nakano.2001.315">Nakano et al 2001</xref>, <xref ref-type="bibr" rid="cfeom.REF.bosley.2006.2363">Bosley et al 2006</xref>].</p>
              </fn>
              <fn id="cfeom.TF.2.11">
                <label>11. </label>
                <p>
                  <xref ref-type="bibr" rid="cfeom.REF.cederquist.2012.5484">Cederquist et al [2012]</xref>
                </p>
              </fn>
              <fn id="cfeom.TF.2.12">
                <label>12. </label>
                <p>A three-generation family that cosegregated CFEOM3 and a balanced/unbalanced reciprocal translocation t(2;13) (q37.3;q12.11) permitted assignment of CFEOM3C, (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/609384">609384</ext-link>) to 13q27.3 [<xref ref-type="bibr" rid="cfeom.REF.aubourg.2005.253">Aubourg et al 2005</xref>]. A genome-wide linkage screen of a large consanguineous family whose affected members have a CFEOM3 phenotype and postaxial oligodactyly/oligosyndactyly of the hands, referred to as Tukel syndrome (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/609428">609428</ext-link>), mapped the locus to a 1.5-Mb region on chromosome 21qter [<xref ref-type="bibr" rid="cfeom.REF.tukel.2005.408">Tukel et al 2005</xref>]. See also <xref ref-type="bibr" rid="cfeom.REF.shinwari.2015.147">Shinwari et al [2015]</xref>.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="cfeom.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="cfeom.Clinical_Description">
          <title>Clinical Description</title>
          <p>Congenital fibrosis of the extraocular muscles (CFEOM) refers to complex strabismus (eye misalignment) syndromes characterized by congenital non-progressive ophthalmoplegia (inability to move the eyes) with or without ptosis (droopy eyelids) affecting part or all of the oculomotor nucleus and nerve (cranial nerve III) and its innervated muscles (superior, medial, and inferior recti, inferior oblique, and levator palpabrae superioris) and/or the trochlear nucleus and nerve (cranial nerve IV) and its innervated muscle (the superior oblique). Magnetic resonance imaging (MRI) suggests that the abducens and optic nerves can also be hypoplastic [<xref ref-type="bibr" rid="cfeom.REF.demer.2005.530">Demer et al 2005</xref>, <xref ref-type="bibr" rid="cfeom.REF.wu.2009.971">Wu et al 2009</xref>, <xref ref-type="bibr" rid="cfeom.REF.demer.2010.4600">Demer et al 2010</xref>].</p>
          <p><bold>Strabismus</bold> is the deviation of the position of one eye relative to the other, resulting in misalignment of the line of site of the two eyes. Individuals with CFEOM typically have incomitant strabismus, in which their misalignment varies with gaze direction. Incomitant strabismus often results from mechanical dysfunction in the orbit or neuromuscular dysfunction at the level of the brain stem, nerve, or muscle. The resting eye position of an individual with CFEOM is often abnormal. In general, hypotropic (downward) and exotropic (outward) positions are more common than hypertropic (upward) and esotropic (inward) positions. Strabismus in individuals with CFEOM can vary within a single family, and this can be particularly remarkable among affected members of families with CFEOM3. Among families with CFEOM1, the vertical strabismus is quite uniform, but the horizontal strabismus can vary.</p>
          <p><bold>Congenital non-progressive external ophthalmoplegia.</bold> Individuals with CFEOM are born with a severe form of incomitant strabismus referred to as ophthalmoplegia (inability to move the eyes) caused by dysfunction of specific ocular muscles innervated by the oculomotor and trochlear nerves. In general, affected individuals have severe limitation of vertical gaze and variable limitation of horizontal gaze. Individuals with CFEOM compensate for the ophthalmoplegia by maintaining an abnormal head position at rest and by moving their heads rather than their eyes to track objects.</p>
          <p><bold>Ptosis</bold> is the drooping of the upper eyelid as a result of dysfunction of the levator palpabrae superioris. Individuals with CFEOM often have a compensatory chin-up head posture to both better position their infraducted eyes and to "see under" their droopy lids.</p>
          <p><bold>Refractive errors</bold> are common but not characteristic.</p>
          <p><bold>Amblyopia.</bold> Strabismus (with suppression of one eye), refractive error, and ptosis may cause amblyopia, which can lead to permanent loss of vision when untreated.</p>
          <p><bold>CNS malformations.</bold> Some individuals with CFEOM have been reported to have central nervous system malformations, including agenesis or hypoplasia of the corpus callosum, brain stem hypoplasia, cerebellar hemisphere hypoplasia, absence of the cerebral peduncle in the midbrain, colpocephaly, hypoplasia of the cerebellar vermis, expansion of the ventricular system, pachygyria, polymicrogyria, encephalocele, and/or hydrancephaly [<xref ref-type="bibr" rid="cfeom.REF.flaherty.2001.1313">Flaherty et al 2001</xref>, <xref ref-type="bibr" rid="cfeom.REF.pieh.2003.546">Pieh et al 2003</xref>, <xref ref-type="bibr" rid="cfeom.REF.harissidagher.2004.540">Harissi-Dagher et al 2004</xref>]. The CFEOM phenotype in most of these individuals is atypical and meets the criteria of CFEOM3. Other CNS findings include hypoplastic oculomotor nerves, dysmorphic basal ganglia with or without internal capsule hypoplasia, and agenesis or hypoplasia of the anterior commissure [<xref ref-type="bibr" rid="cfeom.REF.demer.2010.4600">Demer et al 2010</xref>, <xref ref-type="bibr" rid="cfeom.REF.tischfield.2010.74">Tischfield et al 2010</xref>, <xref ref-type="bibr" rid="cfeom.REF.cederquist.2012.5484">Cederquist et al 2012</xref>, <xref ref-type="bibr" rid="cfeom.REF.chew.2013.522">Chew et al 2013</xref>, <xref ref-type="bibr" rid="cfeom.REF.balasubramanian.2015.e473">Balasubramanian et al 2015</xref>, <xref ref-type="bibr" rid="cfeom.REF.whitman.2016.297">Whitman et al 2016</xref>].</p>
          <p><bold>Non-ocular findings</bold> in a subset of individuals with CFEOM3 include facial paralysis, spasticity, cognitive and behavioral impairments, and a later-onset progressive peripheral sensorimotor axonal polyneuropathy, joint contractures, Kallmann syndrome (hypogonadotropic hypogonadism with anosmia), and cyclic vomiting [<xref ref-type="bibr" rid="cfeom.REF.tischfield.2010.74">Tischfield et al 2010</xref>, <xref ref-type="bibr" rid="cfeom.REF.chew.2013.522">Chew et al 2013</xref>].</p>
          <p><bold>Marcus Gunn phenomenon and other evidence of misinnervation</bold> have been reported in individuals with CFEOM [<xref ref-type="bibr" rid="cfeom.REF.pieh.2003.546">Pieh et al 2003</xref>, <xref ref-type="bibr" rid="cfeom.REF.yamada.2005.1254">Yamada et al 2005</xref>, <xref ref-type="bibr" rid="cfeom.REF.ka_ar_bayram.2015.743">Ka&#x000e7;ar Bayram et al 2015</xref>]. The Marcus Gunn jaw winking phenomenon manifests as the momentary elevation of a ptotic upper eyelid with specific movements of the jaw. Often first noted in young infants when they are feeding, the phenomenon results from aberrant innervation of the levator palpebrae superioris muscle by axons intended to run in the motor branch of the trigeminal nerve and to innervate the pterygoid muscle. The association of this finding with CFEOM provides additional evidence that these syndromes are primarily neurogenic in cause [<xref ref-type="bibr" rid="cfeom.REF.brodsky.1998.717">Brodsky 1998</xref>, <xref ref-type="bibr" rid="cfeom.REF.pieh.2003.546">Pieh et al 2003</xref>].</p>
          <p><bold>Tukel syndrome.</bold> Affected members of the family with CFEOM3 that maps to the Tukel syndrome locus also manifest bilateral postaxial oligodactyly/oligosyndactyly of the hands, more severe on the right.</p>
        </sec>
        <sec id="cfeom.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Each form of CFEOM has a defined phenotype.</p>
          <p><bold><italic toggle="yes">KIF21A</italic></bold> pathogenic variants are associated with CFEOM1 and rare cases of CFEOM3. Clinical examinations and high-resolution orbital MRI of individuals with CFEOM1 resulting from several different specific <italic toggle="yes">KIF21A</italic> pathogenic variants did not reveal a correlation between any specific pathogenic variant and clinical phenotype [<xref ref-type="bibr" rid="cfeom.REF.yamada.2003.318">Yamada et al 2003</xref>, <xref ref-type="bibr" rid="cfeom.REF.demer.2005.530">Demer et al 2005</xref>].</p>
          <p><bold><italic toggle="yes">PHOX2A</italic></bold> pathogenic variants are associated with CFEOM2. No correlation between specific <italic toggle="yes">PHOX2A</italic> pathogenic variants and specific aspects of the CFEOM2 phenotype has been found.</p>
          <p><bold><italic toggle="yes">TUBB3</italic></bold> pathogenic variants are associated with CFEOM1B or CFEOM3. Correlations have been found between specific <italic toggle="yes">TUBB3A</italic> pathogenic variants and the clinical phenotype [<xref ref-type="bibr" rid="cfeom.REF.tischfield.2010.74">Tischfield et al 2010</xref>, <xref ref-type="bibr" rid="cfeom.REF.chew.2013.522">Chew et al 2013</xref>, <xref ref-type="bibr" rid="cfeom.REF.whitman.2016.297">Whitman et al 2016</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p><xref ref-type="table" rid="cfeom.T.selected_tubb3_pathogenic_varian">c.185G&#x0003e;A</xref> (p.Arg62Gln): moderate CFEOM3. Brain MRI: normal. No developmental delays or intellectual disability.</p>
            </list-item>
            <list-item>
              <p><xref ref-type="table" rid="cfeom.T.selected_tubb3_pathogenic_varian">c.784C&#x0003e;T</xref> (p.Arg262Cys): mild to severe CFEOM3 or CFEOM1B. Brain MRI: anterior commissure hypoplasia, mild corpus callosum hypoplasia, mild basal ganglia dysgenesis. No developmental delays or intellectual disability.</p>
            </list-item>
            <list-item>
              <p><xref ref-type="table" rid="cfeom.T.selected_tubb3_pathogenic_varian">c.785G&#x0003e;A</xref> (p.Arg262His): severe CFEOM3, developmental delay, facial weakness, progressive axonal sensorimotor polyneuropathy, congenital joint contractures. Brain MRI: anterior commissure hypoplasia, corpus callosum hypoplasia, basal ganglia dysgenesis.</p>
            </list-item>
            <list-item>
              <p><xref ref-type="table" rid="cfeom.T.selected_tubb3_pathogenic_varian">c.904G&#x0003e;A</xref> (p.Ala302Thr): variable CFEOM3, developmental delay. Brain MRI: anterior commissure hypoplasia, corpus callosum hypoplasia.</p>
            </list-item>
            <list-item>
              <p><xref ref-type="table" rid="cfeom.T.selected_tubb3_pathogenic_varian">c.1138C&#x0003e;T</xref> (p.Arg380Cys): moderate CFEOM3, developmental delay. Brain MRI: anterior commissure hypoplasia, corpus callosum hypoplasia, basal ganglia dysgenesis</p>
            </list-item>
            <list-item>
              <p><xref ref-type="table" rid="cfeom.T.selected_tubb3_pathogenic_varian">c.1249G&#x0003e;A</xref> (p.Asp417Asn): mild to severe CFEOM3 or CFEOM1B, weakness, progressive axonal sensorimotor polyneuropathy. Brain MRI: anterior commissure hypoplasia, mild corpus callosum hypoplasia, mild basal ganglia dysgenesis.</p>
            </list-item>
            <list-item>
              <p><xref ref-type="table" rid="cfeom.T.selected_tubb3_pathogenic_varian">c.1249G&#x0003e;C</xref> (p.Asp417His): severe CFEOM3, developmental delay, facial weakness, progressive axonal sensorimotor polyneuropathy, congenital joint contractures. Brain MRI: anterior commissure hypoplasia.</p>
            </list-item>
            <list-item>
              <p><xref ref-type="table" rid="cfeom.T.selected_tubb3_pathogenic_varian">c.1228G&#x0003e;A</xref> (p.Glu410Lys): severe CFEOM3, developmental delay, facial weakness, midface hypoplasia, Kallmann syndrome (hypogonadotropic hypogonadism with anosmia), progressive sensorimotor polyneuropathy, vocal cord paralysis, and cyclic vomiting. Brain MRI: anterior commissure hypoplasia, corpus callosum hypoplasia, basal ganglia dysgenesis, hypoplastic to absent olfactory bulbs, olfactory sulci, and oculomotor and facial nerves.</p>
            </list-item>
            <list-item>
              <p><xref ref-type="table" rid="cfeom.T.selected_tubb3_pathogenic_varian">c.211G&#x0003e;A</xref> (p.Gly71Arg): moderate CFEOM3, developmental delay, hypotonia, thinning or agenesis of corpus callosum, increased and abnormal cortical gyration, basal ganglia and thalamus dysgenesis, brain stem hypoplasia, incomplete rotation of hippocampus, hypoplasia of optic and oculomotor nerves</p>
            </list-item>
            <list-item>
              <p><xref ref-type="table" rid="cfeom.T.selected_tubb3_pathogenic_varian">c.292G&#x0003e;A</xref> (p.Gly98Ser): moderate CFEOM3, developmental delay, hypotonia, thinning of corpus callosum, increased and abnormal cortical gyration, basal ganglia and thalamus dysgenesis, brain stem hypoplasia, incomplete rotation of hippocampus, cerebellar vermis hypoplasia with dysmorphic folia, hypoplasia of optic and oculmotor nerves</p>
            </list-item>
          </list>
          <p>Many persons with CFEOM3 who have a <italic toggle="yes">TUBB3</italic> pathogenic variant also have aberrant eye movements and several have ptotic eyelid elevation associated with synkinetic jaw movements (Marcus Gunn phenomenon). However, the Marcus Gunn phenomenon has also been reported in association with a <italic toggle="yes">KIF21A</italic> -related CFEOM.</p>
          <p><bold><italic toggle="yes">TUBB2B.</italic></bold> Only one pathogenic variant (c.1261G&#x0003e;A, p.Glu421Lys) has been associated with both CFEOM and polymicrogyria. Seven other pathogenic variants are associated with polymicrogyria without CFEOM.</p>
        </sec>
        <sec id="cfeom.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance in CFEOM1A, CFEOM1B, CFEOM2, CFEOM3B, CFEOM3C, and Tukel syndrome is complete.</p>
          <p>Penetrance in CFEOM3A can be incomplete and is estimated to be 90% in families harboring the <xref ref-type="sec" rid="cfeom.TUBB2B">c.784C&#x0003e;T</xref> (<xref ref-type="sec" rid="cfeom.TUBB2B">p.Arg262Cys</xref>) substitution [<xref ref-type="bibr" rid="cfeom.REF.doherty.1999.1687">Doherty et al 1999</xref>].</p>
        </sec>
        <sec id="cfeom.Nomenclature">
          <title>Nomenclature</title>
          <p>Although long felt to result from primary fibrosis of the extraocular muscles, neuroanatomic [<xref ref-type="bibr" rid="cfeom.REF.engle.1997.314">Engle et al 1997</xref>, <xref ref-type="bibr" rid="cfeom.REF.tischfield.2010.74">Tischfield et al 2010</xref>], genetic [<xref ref-type="bibr" rid="cfeom.REF.nakano.2001.315">Nakano et al 2001</xref>, <xref ref-type="bibr" rid="cfeom.REF.yamada.2003.318">Yamada et al 2003</xref>, <xref ref-type="bibr" rid="cfeom.REF.tischfield.2010.74">Tischfield et al 2010</xref>], and neuroimaging [<xref ref-type="bibr" rid="cfeom.REF.demer.2005.530">Demer et al 2005</xref>, <xref ref-type="bibr" rid="cfeom.REF.kim.2005.728">Kim &#x00026; Hwang 2005</xref>, <xref ref-type="bibr" rid="cfeom.REF.bosley.2006.2363">Bosley et al 2006</xref>, <xref ref-type="bibr" rid="cfeom.REF.lim.2007.1601">Lim et al 2007</xref>, <xref ref-type="bibr" rid="cfeom.REF.wu.2009.971">Wu et al 2009</xref>, <xref ref-type="bibr" rid="cfeom.REF.demer.2010.4600">Demer et al 2010</xref>] findings suggest that the various forms of CFEOM result from abnormal development of ocular motor neurons and their processes.</p>
        </sec>
        <sec id="cfeom.Prevalence">
          <title>Prevalence</title>
          <p>A minimum prevalence of CFEOM is 1:230,000 [<xref ref-type="bibr" rid="cfeom.REF.reck.1998.676">Reck et al 1998</xref>].</p>
          <p>CFEOM1 and CFEOM3 familial and simplex cases have been identified worldwide.</p>
          <p>The few individuals reported with CFEOM2 have been offspring of consanguineous unions within Saudi, Turkish, and Iranian families [<xref ref-type="bibr" rid="cfeom.REF.traboulsi.2004.237">Traboulsi &#x00026; Engle 2004</xref>].</p>
        </sec>
      </sec>
      <sec id="cfeom.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold><italic toggle="yes">KIF21A</italic>, <italic toggle="yes">PHOX2A.</italic></bold> No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are associated with pathogenic variants in <italic toggle="yes">KIF21A</italic> or <italic toggle="yes">PHOX2A</italic>.</p>
        <p><bold><italic toggle="yes">TUBB3.</italic></bold> A distinct set of pathogenic variants in TUBB3 cause malformations of cortical development without CFEOM [<xref ref-type="bibr" rid="cfeom.REF.poirier.2010.4462">Poirier et al 2010</xref>, <xref ref-type="bibr" rid="cfeom.REF.bahibuisson.2014.1676">Bahi-Buisson et al 2014</xref>, <xref ref-type="bibr" rid="cfeom.REF.falletbianco.2014.69">Fallet-Bianco et al 2014</xref>, <xref ref-type="bibr" rid="cfeom.REF.oegema.2015.5313">Oegema et al 2015</xref>]. Individuals with these variants have intellectual disability, motor delays, and malformations of cortical development associated with neuronal migration and differentiation defects and axonal guidance and tract organization impairment (in the absence of CFEOM). MRI revealed a common complex cortical dysgenesis that combined frontally predominant microgyria or gyral disorganization and simplification, dysmorphic and hypertropic basal ganglia with fusion between putamen and caudate nucleus, cerebellar vermian dysplasia, hypoplastic brain stem, and hypoplastic corpus callosum. Sequence analysis identified pathogenic variants in 6% (7/120) of individuals with this phenotype (6 novel pathogenic variants in 7 probands).</p>
        <p>A subset of individuals with <italic toggle="yes">TUBB3</italic> pathogenic variants have facial weakness in addition to limited horizontal gaze; this can be confused with Moebius syndrome, but individuals with <italic toggle="yes">TUBB3</italic> variants have eyes fixed in abduction while those with Moebius syndrome have marked limitation of abduction [<xref ref-type="bibr" rid="cfeom.REF.mackinnon.2014.1461">MacKinnon et al 2014</xref>].</p>
        <p><bold><italic toggle="yes">TUBB2B.</italic></bold> Pathogenic variants in <italic toggle="yes">TUBB2B</italic> have been associated with microlissencephaly or polymicrogyria, usually accompanied by abnormalities of the corpus collosum and cerebellar, basal ganglia, and brain stem dysplasia, but without CFEOM [<xref ref-type="bibr" rid="cfeom.REF.jaglin.2009.746">Jaglin et al 2009</xref>, <xref ref-type="bibr" rid="cfeom.REF.bahibuisson.2014.1676">Bahi-Buisson et al 2014</xref>, <xref ref-type="bibr" rid="cfeom.REF.falletbianco.2014.69">Fallet-Bianco et al 2014</xref>, <xref ref-type="bibr" rid="cfeom.REF.oegema.2015.5313">Oegema et al 2015</xref>].</p>
      </sec>
      <sec id="cfeom.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The term 'congenital cranial dysinnervation disorders (CCDDs)' was coined to refer to disorders of innervation of cranial musculature [<xref ref-type="bibr" rid="cfeom.REF.gutowski.2003.573">Gutowski et al 2003</xref>]. The various forms of CFEOM are included in the CCDDs. Other CCDDs include Duane syndrome, Moebius syndrome, and congenital facial palsy.</p>
        <p>The following conditions can be confused with CFEOM:</p>
        <p><bold>Brown syndrome</bold> ('superior oblique tendon sheath syndrome') is characterized by the inability to elevate the adducted eye actively or passively. Most congenital Brown syndrome is simplex (i.e., a single occurrence in a family) and believed to result from anomalies of the tendon or the trochlear apparatus. Rare familial cases have been reported [<xref ref-type="bibr" rid="cfeom.REF.iannaccone.2002.175">Iannaccone et al 2002</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="duane" document-type="chapter"><bold>Duane syndrome</bold></related-object> is characterized by horizontal eye movement limitation, narrowing of the palpebral fissure on attempted side gaze (usually adduction), and retraction of the globe on attempted adduction. It is believed to result from abnormal development of the abducens nucleus and nerve (cranial nerve VI).</p>
        <p>Although the majority of cases of Duane syndrome are simplex and isolated (i.e., not associated with other malformations), rare families with autosomal dominant or autosomal recessive inheritance of Duane syndrome with or without accompanying anomalies have been reported:</p>
        <list list-type="bullet">
          <list-item>
            <p>An autosomal dominant locus for Duane syndrome was mapped by linkage analysis to 2q31 (DURS2, OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/604356">604356</ext-link>). All affected individuals had bilateral Duane syndrome type 1 or type 3; the prevalence of manifest strabismus and amblyopia was high. Heterozygous missense changes in <italic toggle="yes">CHN1</italic> that cosegregated with the affected haplotypes were identified [<xref ref-type="bibr" rid="cfeom.REF.miyake.2008.839">Miyake et al 2008</xref>]. All were predicted to alter amino acids that were conserved in eight different species. <italic toggle="yes">CHN1</italic> was subsequently found not to be a common cause of sporadic Duane syndrome [<xref ref-type="bibr" rid="cfeom.REF.miyake.2010.215">Miyake et al 2010</xref>].</p>
          </list-item>
          <list-item>
            <p>A contiguous gene deletion syndrome with Duane syndrome is located on 8q13 (DURS1, OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/126800">126800</ext-link>).</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="drrs" document-type="chapter"><bold><italic toggle="yes">SALL4</italic>-related disorders</bold></related-object><bold>.</bold> The <italic toggle="yes">SALL4</italic>-related syndromes include Okihiro syndrome, Duane-radial ray syndrome, acro-renal-ocular syndrome, and IVIC syndrome. These overlapping syndromes are characterized by unilateral or bilateral Duane syndrome and radial ray malformations that can include thenar hypoplasia and/or hypoplasia or aplasia of the thumbs; hypoplasia or aplasia of the radii; shortening and radial deviation of the forearms; triphalangeal thumbs; and duplication of the thumb (preaxial polydactyly). Deafness, renal anomalies, and imperforate anus can be coinherited. Inheritance is autosomal dominant.</p>
            <p>Heterozygous <italic toggle="yes">SALL4</italic> pathogenic variants are associated with most familial cases of these syndromes [<xref ref-type="bibr" rid="cfeom.REF.albaradie.2002.1195">Al-Baradie et al 2002</xref>, <xref ref-type="bibr" rid="cfeom.REF.kohlhase.2002.2979">Kohlhase et al 2002</xref>]. Individuals who represent simplex cases of isolated Duane syndrome have not been found to harbor pathogenic variants in <italic toggle="yes">SALL4</italic> [<xref ref-type="bibr" rid="cfeom.REF.wabbels.2004.216">Wabbels et al 2004</xref>]. However, some members of families segregating a <italic toggle="yes">SALL4-</italic>related disorder have been found to harbor a <italic toggle="yes">SALL4</italic> pathogenic variant and to manifest isolated Duane syndrome (without hand or other anomalies) [<xref ref-type="bibr" rid="cfeom.REF.albaradie.2002.1195">Al-Baradie et al 2002</xref>].</p>
          </list-item>
          <list-item>
            <p>Athabaskan brain stem dysgenesis syndrome (ABDS) [<xref ref-type="bibr" rid="cfeom.REF.holve.2003.169">Holve et al 2003</xref>] and Bosley-Salih-Alorainy syndrome (BSAS) [<xref ref-type="bibr" rid="cfeom.REF.tischfield.2005.1035">Tischfield et al 2005</xref>] (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/601536">601536</ext-link>) are autosomal recessive disorders that result from pathogenic variants in <italic toggle="yes">HOXA1</italic> [<xref ref-type="bibr" rid="cfeom.REF.tischfield.2005.1035">Tischfield et al 2005</xref>]. They are characterized by Duane syndrome type III or horizontal gaze palsy and, in most individuals, bilateral sensorineural hearing loss caused by absent cochlea and rudimentary inner ear development. Depending on the specific syndrome (ABDS vs. BSAS), a subset of individuals manifests intellectual disability, autism, moderate to severe central hypoventilation, facial weakness, swallowing difficulties, vocal cord paresis, conotruncal heart defects, and skull and craniofacial abnormalities.</p>
          </list-item>
        </list>
        <p><bold>Chronic progressive external ophthalmoplegia (CPEO)</bold> is characterized by chronic progressive loss of extraocular eye movements and ptosis.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="kss" document-type="chapter"><bold>Mitochondrial DNA deletion syndromes</bold></related-object> comprise three overlapping phenotypes, which may be observed in different members of the same family or may evolve in a given individual over time. The three phenotypes are: Kearns-Sayre syndrome (KSS), Pearson syndrome, and progressive external ophthalmoplegia (PEO). These syndromes are caused by mtDNA deletions ranging in size from two to ten kilobases.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>KSS</bold> is defined by the triad of onset before age 20 years, pigmentary retinopathy, and PEO. Individuals additionally have at least one of the following: cardiac conduction block, cerebrospinal fluid protein concentration greater than 100 mg/dL, or cerebellar ataxia. Approximately 90% of individuals with KSS have a large-scale (i.e., 1.3- to 10-kb) mtDNA deletion that is usually present in all tissues; however, mutated mtDNA is often undetectable in blood cells, necessitating examination of muscle.</p>
          </list-item>
          <list-item>
            <p><bold>Pearson syndrome</bold> is characterized by sideroblastic anemia and exocrine pancreas dysfunction. In Pearson syndrome, mtDNA deletions are usually more abundant in blood than in other tissues.</p>
          </list-item>
          <list-item>
            <p><bold>PEO</bold> is characterized by progressive ptosis, paralysis of the extraocular muscles (ophthalmoplegia), and variably severe proximal limb weakness.</p>
          </list-item>
        </list>
        <p>Other disorders associated with ophthalmoplegia include (with distinguishing features) the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Myasthenia gravis (fluctuating weakness and diplopia); see <related-object link-type="booklink" source-id="gene" document-id="cms" document-type="chapter">Congenital Myasthenic Syndromes</related-object>.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="opmd" document-type="chapter">Oculopharyngeal muscular dystrophy</related-object> (late-onset severe dysphagia, autosomal dominant inheritance; caused by an expansion of a GCG trinucleotide repeat in the first exon of <italic toggle="yes">PABPN1,</italic> the gene encoding polyadenylate binding protein nuclear 1)</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="myotonic-d" document-type="chapter">Myotonic dystrophy type 1</related-object> (myotonia, autosomal dominant inheritance; caused by expansion of a CTG trinucleotide repeat in <italic toggle="yes">DMPK</italic>)</p>
          </list-item>
          <list-item>
            <p>Mendelian PEOs associated with multiple deletions of mtDNA caused by pathogenic variants in the nuclear genes <italic toggle="yes">SLC25A4</italic>, <italic toggle="yes">PEO1</italic>, <italic toggle="yes">POLG</italic>, and <italic toggle="yes">TMPO</italic> (autosomal dominant or recessive inheritance; affective disorders, gastrointestinal dysmotility); see <related-object link-type="booklink" source-id="gene" document-id="alpers" document-type="chapter"><italic toggle="yes">POLG</italic>-Related Disorders</related-object>.</p>
          </list-item>
          <list-item>
            <p>Maternally inherited PEOs caused by various mtDNA pathogenic variants</p>
          </list-item>
        </list>
        <p><bold>Cranial nerve III and IV palsy.</bold> Few reports of congenital familial third-nerve palsy or fourth-nerve palsy exist. The etiologies of these disorders are unknown.</p>
        <p><bold>Horizontal gaze palsy with progressive scoliosis (HGPPS)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/607313">607313</ext-link>) is characterized by congenital horizontal gaze palsy (no horizontal eye movements) with progressive scoliosis inherited in an autosomal recessive manner and caused by pathogenic variants in <italic toggle="yes">ROBO3</italic> [<xref ref-type="bibr" rid="cfeom.REF.jen.2004.1509">Jen et al 2004</xref>]. Compound heterozygous <italic toggle="yes">ROBO3</italic> pathogenic variants have also been identified in children of non-consanguineous parents [<xref ref-type="bibr" rid="cfeom.REF.chan.2006.e11">Chan et al 2006</xref>]. Results of neuroimaging and neurophysiology studies undertaken on individuals with HGPPS found that the axons that make up the major motor and sensory pathways for communication between the brain and the body fail to cross the midline in the hindbrain [<xref ref-type="bibr" rid="cfeom.REF.jen.2004.1509">Jen et al 2004</xref>, <xref ref-type="bibr" rid="cfeom.REF.bosley.2005.1196">Bosley et al 2005</xref>].</p>
        <p><bold>Moebius syndrome (MBS)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/157900">157900</ext-link>) is characterized by facial weakness or diplegia with ocular abduction deficit.</p>
        <list list-type="bullet">
          <list-item>
            <p>The vast majority of individuals with Moebius syndrome represent simplex cases and many are associated with developmental defects of additional lower cranial nerves and distal extremities.</p>
          </list-item>
          <list-item>
            <p>Moebius sequence has also been reported in association with congenital non-progressive myopathy and Robin sequence (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/254940">254940</ext-link>)</p>
          </list-item>
        </list>
        <p><bold>Hereditary congenital facial paresis,</bold> the isolated dysfunction of the facial nerve, maps to chromosome 3q (locus HCFP1) (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/601471">601471</ext-link>) and chromosome 10q (locus HCFP2) (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/604185">604185</ext-link>).</p>
        <p><bold>Other.</bold> CFEOM has been identified in one individual with <related-object link-type="booklink" source-id="gene" document-id="noonan" document-type="chapter">Noonan syndrome</related-object> [<xref ref-type="bibr" rid="cfeom.REF.elgohary.2005.319">Elgohary et al 2005</xref>].</p>
      </sec>
      <sec id="cfeom.Management">
        <title>Management</title>
        <sec id="cfeom.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with congenital fibrosis of the extraocular muscles, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic examination</p>
              <list list-type="bullet">
                <list-item>
                  <p>Determination of resting gaze position, head position with eyes in resting gaze position, and vertical and horizontal gaze restrictions</p>
                </list-item>
                <list-item>
                  <p>Evaluation for aberrant movements including synergistic convergence and divergence, globe retraction, Marcus Gunn jaw wink</p>
                </list-item>
                <list-item>
                  <p>Palpebral fissure size measurement</p>
                </list-item>
                <list-item>
                  <p>Anterior segment evaluation to detect corneal exposure</p>
                </list-item>
                <list-item>
                  <p>Levator function testing</p>
                </list-item>
                <list-item>
                  <p>Optional forced duction testing</p>
                </list-item>
                <list-item>
                  <p>Refraction, including cycloplegic refraction in children</p>
                </list-item>
                <list-item>
                  <p>Photographic documentation for future comparison</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Neuroimaging suggested if there are any additional neurologic symptoms or developmental delays</p>
            </list-item>
            <list-item>
              <p>Strongly recommended if eye muscle surgery is planned:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Brain and brain stem MRI scan to determine the size and/or course of the oculomotor and trochlear nerves</p>
                </list-item>
                <list-item>
                  <p>High-resolution orbital MRI (1- to 3-mm cuts) to detect abnormalities in the size and/or course of the extraocular muscle(s) and atrophy of the superior rectus-levator complex</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="cfeom.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Nonsurgical treatment</bold> of ophthalmologic findings:</p>
          <list list-type="bullet">
            <list-item>
              <p>Refractive errors may be managed with spectacles or contact lenses. Specialist examination is required to detect refractive errors early in life, when affected individuals may be asymptomatic, to prevent amblyopia and avoid compounding the motility problem with a focusing problem.</p>
            </list-item>
            <list-item>
              <p>Amblyopia can be treated effectively with occlusion or penalization of the better-seeing eye. Early detection (in the first years of life) maximizes the likelihood of a good response to treatment.</p>
            </list-item>
            <list-item>
              <p>Lubrication of ocular surface (particularly cornea) may be required. In cases of severe exposure, a PROSE lens can be of significant benefit [<xref ref-type="bibr" rid="cfeom.REF.papakostas.2015.248">Papakostas et al 2015</xref>].</p>
            </list-item>
          </list>
          <p><bold>Surgical treatment</bold> of ophthalmologic findings (extraocular muscle and/or ptosis surgery):</p>
          <list list-type="bullet">
            <list-item>
              <p>Correction of ptosis</p>
            </list-item>
            <list-item>
              <p>Eye muscle surgery</p>
              <list list-type="bullet">
                <list-item>
                  <p>To correct or improve a compensatory head posture</p>
                </list-item>
                <list-item>
                  <p>To improve alignment in primary gaze position</p>
                </list-item>
                <list-item>
                  <p>To improve ambulation and gross motor development in young children</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Principles of surgical approach:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Orbital imaging is recommended before surgery to assess muscle size and position.</p>
                </list-item>
                <list-item>
                  <p>Extraocular muscles may be found at surgery to be attached in unexpected locations.</p>
                </list-item>
                <list-item>
                  <p>Resections or plications may be helpful in some cases to provide traction against large recessions during healing.</p>
                </list-item>
                <list-item>
                  <p>Surgery is likely to be technically difficult because of tightness of rectus muscles.</p>
                </list-item>
                <list-item>
                  <p>Recessions need to be larger &#x02013; sometimes considerably larger &#x02013; than indicated by standard tables, especially recessions of the inferior rectus muscles.</p>
                </list-item>
                <list-item>
                  <p>Dysinnervation causing esotropia in attempted upgaze may mask an underlying exotropia that will be unmasked after inferior rectus muscle weakening.</p>
                </list-item>
                <list-item>
                  <p>Inferior rectus muscle weakening may be enhanced by superior oblique weakening.</p>
                </list-item>
                <list-item>
                  <p>Profound weakening procedures (e.g., suturing muscle to orbital rim, rectus muscle myectomy) may be necessary.</p>
                </list-item>
                <list-item>
                  <p>Botulinum toxin may be helpful for residual misalignment in some cases.</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="cfeom.Prevention_of_Secondary_Complicati">
          <title>Prevention of Secondary Complications</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Amblyopia therapy to prevent vision loss in the less-preferred eye</p>
            </list-item>
            <list-item>
              <p>Eye lubrication to avoid dry eyes, particularly following ptosis surgery but also after successful strabismus surgery in some cases</p>
            </list-item>
            <list-item>
              <p>Surgical repositioning of the eyes and lids to help correct head position and alleviate secondary musculoskeletal complications from chronic head turn</p>
            </list-item>
          </list>
        </sec>
        <sec id="cfeom.Surveillance">
          <title>Surveillance</title>
          <p>CFEOM is congenital and is believed to be non-progressive.</p>
          <p>Surveillance is important for prevention of amblyopia, and to treat amblyopia and complications of corneal exposure [<xref ref-type="bibr" rid="cfeom.REF.yazdani.2004.1035">Yazdani &#x00026; Traboulsi 2004</xref>].</p>
          <p>Routine ophthalmologic care is indicated, with visits every three to four months during the first years of life, and annual or biannual examinations in affected individuals not at risk for amblyopia.</p>
          <p>In individuals with specific <italic toggle="yes">TUBB3</italic> variants, surveillance for endocrine abnormalities, facial or vocal cord weakness, and interventions for developmental delays are indicated.</p>
        </sec>
        <sec id="cfeom.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate relatives at risk in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures.</p>
          <list list-type="bullet">
            <list-item>
              <p>If the pathogenic variant(s) in the family are known, molecular genetic testing can be used to clarify the genetic status of at-risk relatives.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant(s) in the family are not known, clinical ophthalmologic exam can be used to clarify the disease status of at-risk relatives.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="cfeom.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="cfeom.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="cfeom.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="cfeom.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Congenital fibrosis of the extraocular muscles (CFEOM) 1 (mutation of <italic toggle="yes">KIF21A</italic> or <italic toggle="yes">TUBB3</italic>), CFEOM3 (mutation of <italic toggle="yes">TUBB3</italic>, <italic toggle="yes">TUBB2B</italic>, or <italic toggle="yes">KIF21A</italic>), and CFEOM3 with polymicrogyria (mutation of <italic toggle="yes">TUBB2B</italic>) are inherited in an autosomal dominant manner.</p>
          <p>CFEOM2 (mutation of <italic toggle="yes">PHOX2A</italic>) and Tukel syndrome (molecular basis unknown) are inherited in an autosomal recessive manner.</p>
          <sec id="cfeom.Risk_to_Family_Members__Autosomal">
            <title>Risk to Family Members &#x02013; Autosomal Dominant Inheritance (CFEOM1, CFEOM3, CFEOM3 with Polymicrogyria)</title>
            <p>
              <bold>Parents of a proband</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Some individuals diagnosed with CFEOM1, CFEOM3, or CFEOM3 with polymicrogyria have an affected parent.</p>
              </list-item>
              <list-item>
                <p>A proband may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant in <italic toggle="yes">KIF21A</italic>, <italic toggle="yes">TUBB3</italic>, or <italic toggle="yes">TUBB2B</italic>.</p>
                <list list-type="bullet">
                  <list-item>
                    <p><bold><italic toggle="yes">KIF21A</italic>.</bold>
<italic toggle="yes">De novo</italic> pathogenic variants have been reported (see <xref ref-type="bibr" rid="cfeom.REF.yamada.2003.318">Yamada et al [2003]</xref>).</p>
                  </list-item>
                  <list-item>
                    <p><bold><italic toggle="yes">TUBB3</italic>.</bold> The proportion of cases caused by a <italic toggle="yes">de novo</italic> pathogenic variant among patients with isolated CFEOM3 (no other neurologic deficits) has been reported to be 25% (4/16 pedigrees) [<xref ref-type="bibr" rid="cfeom.REF.tischfield.2010.74">Tischfield et al 2010</xref>]. Probands with CFEOM3A with additional neurological deficits are usually the result of <italic toggle="yes">de novo</italic>
<italic toggle="yes">TUBB3</italic> pathogenic variant (85%, 17/20 pedigrees) [<xref ref-type="bibr" rid="cfeom.REF.tischfield.2010.74">Tischfield et al 2010</xref>, <xref ref-type="bibr" rid="cfeom.REF.chew.2013.522">Chew et al 2013</xref>, <xref ref-type="bibr" rid="cfeom.REF.balasubramanian.2015.e473">Balasubramanian et al 2015</xref>, <xref ref-type="bibr" rid="cfeom.REF.whitman.2016.297">Whitman et al 2016</xref>].</p>
                  </list-item>
                  <list-item>
                    <p><bold><italic toggle="yes">TUBB2B</italic>.</bold> The proportion of cases caused by a <italic toggle="yes">de novo</italic>
<italic toggle="yes">TUBB2B</italic> pathogenic variant is unknown.</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic>
<italic toggle="yes">KIF21A</italic>, <italic toggle="yes">TUBB3</italic>, or <italic toggle="yes">TUBB2B</italic> pathogenic variant include ophthalmologic examinations and consideration of molecular genetic testing for the pathogenic variant if one has been identified in the proband.</p>
              </list-item>
              <list-item>
                <p>If a <italic toggle="yes">KIF21A</italic>, <italic toggle="yes">TUBB3</italic>, or <italic toggle="yes">TUBB2B</italic> pathogenic variant cannot be detected in the leukocyte DNA of either parent, possible explanations include a <italic toggle="yes">de novo</italic> pathogenic variant in the proband or germline mosaicism in a parent.</p>
                <list list-type="bullet">
                  <list-item>
                    <p><bold><italic toggle="yes">KIF21A</italic>.</bold> Two families with parental germline mosaicism have been reported [<xref ref-type="bibr" rid="cfeom.REF.liu.2014.15">Liu et al 2014</xref>].</p>
                  </list-item>
                  <list-item>
                    <p><bold><italic toggle="yes">TUBB3.</italic></bold> Two families with presumed parental germline mosaicism have been reported [<xref ref-type="bibr" rid="cfeom.REF.tischfield.2010.74">Tischfield et al 2010</xref>].</p>
                  </list-item>
                  <list-item>
                    <p><bold><italic toggle="yes">TUBB2B.</italic></bold> No cases of parental germline mosaicism have been reported.</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p>The family history of some individuals diagnosed with CFEOM1, CFEOM3, or CFEOM3 with polymicrogyria may appear to be negative because of failure to recognize the disorder in family members or reduced penetrance. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations (e.g., ocular examination and/or molecular genetic testing) have been performed on the parents of the proband.</p>
              </list-item>
            </list>
            <p>
              <bold>Sibs of a proband</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>The risk to sibs of a proband depends on the genetic status of the proband's parents.</p>
              </list-item>
              <list-item>
                <p>If a parent has clinical characteristics consistent with CFEOM and/or a pathogenic variant in <italic toggle="yes">KIF21A</italic>, <italic toggle="yes">TUBB3</italic>, or <italic toggle="yes">TUBB2B</italic>, the risk to the sibs is 50%. The chance that a sib who inherits the pathogenic variant will manifest CFEOM may be less than 50% depending on the penetrance of the variant (see <xref ref-type="sec" rid="cfeom.Penetrance">Penetrance</xref>).</p>
              </list-item>
              <list-item>
                <p>The sibs of a proband with clinically unaffected parents are still at increased risk for CFEOM because of the possibility of reduced penetrance in a parent.</p>
              </list-item>
              <list-item>
                <p>If the pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
              </list-item>
            </list>
            <p><bold>Offspring of a proband.</bold> Each child of an individual with CFEOM1, CFEOM3, or CFEOM3 with polymicrogyria has a 50% chance of inheriting the pathogenic variant.</p>
            <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the genetic status of the proband's parents: if a parent is affected and/or has a pathogenic variant, his or her family members are at risk.</p>
          </sec>
          <sec id="cfeom.Risk_to_Family_Members__Autosomal_1">
            <title>Risk to Family Members &#x02013; Autosomal Recessive Inheritance (CFEOM2 and Tukel Syndrome)</title>
            <p>
              <bold>Parents of a proband</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>The parents of an individual with CFEOM2 or Tukel syndrome are obligate heterozygotes (i.e., carriers of one pathogenic variant).</p>
              </list-item>
              <list-item>
                <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
              </list-item>
              <list-item>
                <p>Pseudodominant inheritance (i.e., an autosomal recessive condition present in individuals in two or more generations) of CFEOM2 has been reported in two consanguineous families [<xref ref-type="bibr" rid="cfeom.REF.wang.1998.517">Wang et al 1998</xref>] (see <xref ref-type="sec" rid="cfeom.Prevalence">Prevalence</xref>). Two-generation involvement can occur in autosomal recessive disorders when a parent (who has 2 pathogenic alleles) is affected and his/her reproductive partner is a carrier.</p>
              </list-item>
            </list>
            <p>
              <bold>Sibs of a proband</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>At conception, each sib of an individual with CFEOM2 or Tukel syndrome has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
              </list-item>
              <list-item>
                <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
              </list-item>
            </list>
            <p><bold>Offspring of a proband.</bold> The offspring of an individual with CFEOM2 or Tukel syndrome are obligate heterozygotes (carriers) for a pathogenic variant.</p>
            <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier of a pathogenic variant.</p>
          </sec>
        </sec>
        <sec id="cfeom.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p><bold>CFEOM2.</bold> Carrier testing for relatives at risk requires prior identification of the <italic toggle="yes">PHOX2A</italic> pathogenic variants in the family.</p>
          <p><bold>Tukel syndrome.</bold> Carrier testing using molecular genetic techniques is not possible because the associated gene has not been identified.</p>
        </sec>
        <sec id="cfeom.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="cfeom.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant</bold>. When neither parent of a proband with an autosomal dominant condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> pathogenic variant. However, non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="cfeom.Prenatal_Testing_and_Preimplantati">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">KIF21A</italic>, <italic toggle="yes">TUBB3</italic>, <italic toggle="yes">TUBB2B</italic>, or <italic toggle="yes">PHOX2A</italic> pathogenic variant(s) have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for CFEOM are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="cfeom.Resources">
        <title>Resources</title>
      </sec>
      <sec id="cfeom.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="cfeom.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>CFEOM is a cranial motor neuron disorder caused by pathogenic variants in the genes encoding KIF21A, PHOX2A, TUBB3, and TUBB2B. These proteins are expressed in tissues affected in CFEOM, as well as many other tissues. KIF21A is expressed widely in the cell bodies, axons and dendrites of multiple neuronal populations, as well as extraocular and other skeletal muscles [<xref ref-type="bibr" rid="cfeom.REF.yamada.2003.318">Yamada et al 2003</xref>, <xref ref-type="bibr" rid="cfeom.REF.desai.2012.180">Desai et al 2012</xref>]. TUBB3 is expressed primarily in neurons [<xref ref-type="bibr" rid="cfeom.REF.katsetos.2003.851">Katsetos et al 2003</xref>]. TUBB2B is highly expressed in both neurons and glia.</p>
          <p>Microtubules are copolymers assembled from tubulin heterodimers, which contain several different alpha- and &#x003b2;-tubulin isotypes encoded by separate genes. KIF21A, a member of the kinesin family of molecular motors, interacts with the microtubule track to transport cargos in an anterograde direction from the cell body to the developing growth cone [<xref ref-type="bibr" rid="cfeom.REF.marszalek.1999.469">Marszalek et al 1999</xref>]. TUBB3 and TUBB2B are components of the microtubules. PHOX2A is a homeodomain transcription factor protein that plays a primary role in the oculomotor and trochlear alpha motor neuron development in mice and zebrafish [<xref ref-type="bibr" rid="cfeom.REF.pattyn.1997.4065">Pattyn et al 1997</xref>, <xref ref-type="bibr" rid="cfeom.REF.guo.1999.555">Guo et al 1999</xref>].</p>
          <sec id="cfeom.KIF21A">
            <title>
              <italic toggle="yes">KIF21A</italic>
            </title>
            <p><bold>Gene structure.</bold> The normal cDNA comprises 5,022 bp in 38 exons with alternative splicing of exon 12 and exons 29-31. Genomic length is approximately 150 kb [<xref ref-type="bibr" rid="cfeom.REF.yamada.2003.318">Yamada et al 2003</xref>]. Alternative splicing results in cDNAs of varying lengths. Reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001173464.1">NM_001173464.1</ext-link> (<xref ref-type="table" rid="cfeom.T.selected_kif21a_pathogenic_varia">Table 3</xref>) is the longest transcript variant. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cfeom" object-id="cfeom.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Ten heterozygous missense <italic toggle="yes">KIF21A</italic> variants have been associated with CFEOM1 [<xref ref-type="bibr" rid="cfeom.REF.yamada.2003.318">Yamada et al 2003</xref>, <xref ref-type="bibr" rid="cfeom.REF.ali.2004.247">Ali et al 2004</xref>, <xref ref-type="bibr" rid="cfeom.REF.tiab.2004.241">Tiab et al 2004</xref>, <xref ref-type="bibr" rid="cfeom.REF.lin.2005.245">Lin et al 2005</xref>, <xref ref-type="bibr" rid="cfeom.REF.shimizu.2005.443">Shimizu et al 2005</xref>, <xref ref-type="bibr" rid="cfeom.REF.chan.2007.26">Chan et al 2007</xref>, <xref ref-type="bibr" rid="cfeom.REF.lu.2008.388">Lu et al 2008</xref>, <xref ref-type="bibr" rid="cfeom.REF.rudolph.2009.667">Rudolph et al 2009</xref>, <xref ref-type="bibr" rid="cfeom.REF.khan.2010.154">Khan et al 2010</xref>] and CFEOM3 [<xref ref-type="bibr" rid="cfeom.REF.yamada.2004.2218">Yamada et al 2004</xref>, <xref ref-type="bibr" rid="cfeom.REF.lin.2005.245">Lin et al 2005</xref>, <xref ref-type="bibr" rid="cfeom.REF.lu.2008.388">Lu et al 2008</xref>, <xref ref-type="bibr" rid="cfeom.REF.yang.2010.2062">Yang et al 2010</xref>]. One missense variant was identified in one CFEOM3 pedigree [<xref ref-type="bibr" rid="cfeom.REF.yamada.2004.2218">Yamada et al 2004</xref>].</p>
            <p>In a study of 127 probands, the pathogenic variant c.2860C&#x0003e;T accounted for more than 40% of abnormal alleles. Seven of these <italic toggle="yes">KIF21A</italic> pathogenic variants occur at only three amino-acid residues, each located in the 'a' position of a heptad repeat within an alpha helical coiled-coil region of the KIF21A stalk. The c.84C&#x0003e;G and c.1067T&#x0003e;C pathogenic variants are located in the motor domain. Haplotype analysis demonstrated that five <italic toggle="yes">de novo</italic> pathogenic variants found in autosomal dominant CFEOM1 pedigrees all arose exclusively on the paternal allele [<xref ref-type="bibr" rid="cfeom.REF.yamada.2003.318">Yamada et al 2003</xref>].</p>
            <table-wrap id="cfeom.T.selected_kif21a_pathogenic_varia" orientation="portrait" position="anchor">
              <label>Table 3. </label>
              <caption>
                <p>Selected <italic toggle="yes">KIF21A</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.84C&#x0003e;G</td>
                    <td headers="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys28Trp</td>
                    <td headers="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001173464.1">NM_001173464.1</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_001166935.1">NP_001166935.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1067T&#x0003e;C</td>
                    <td headers="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Met356Thr</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2860C&#x0003e;T</td>
                    <td headers="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg954Trp</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> The predicted protein, encoded by transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001173464.1">NM_001173464.1</ext-link>, kinesin family member 21A (KIF21A), is 1674 amino acids and comprises three domains characteristic of the kinesin superfamily: an N-terminal motor domain that interacts with the microtubule track, a central coiled-coil stalk, and a C-terminal tail that loads or interacts with transported cargo [<xref ref-type="bibr" rid="cfeom.REF.marszalek.1999.469">Marszalek et al 1999</xref>]. See <xref ref-type="sec" rid="cfeom.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>.</p>
            <p>Kif21a mRNA and protein are expressed early during mouse development highly in the brain and moderately in the kidney, testes, and skeletal muscle [<xref ref-type="bibr" rid="cfeom.REF.marszalek.1999.469">Marszalek et al 1999</xref>]. Kif21a is hypothesized to interact with the insoluble cytoskeleton or a large protein complex [<xref ref-type="bibr" rid="cfeom.REF.marszalek.1999.469">Marszalek et al 1999</xref>]. In vitro, KIF21A acts as an inhibitor of microtubule dynamics [<xref ref-type="bibr" rid="cfeom.REF.van_der_vaart.2013.145">van der Vaart et al 2013</xref>].</p>
            <p><bold>Abnormal gene product.</bold> In vivo and in vitro, CFEOM-causing pathogenic variants in <italic toggle="yes">KIF21A</italic> attenuate normal autoinhibition of the protein, leading to a constitutively active molecule, increased microtubule association, and oculomotor axon stalling [<xref ref-type="bibr" rid="cfeom.REF.cheng.2014.334">Cheng et al 2014</xref>].</p>
          </sec>
          <sec id="cfeom.PHOX2A">
            <title>
              <italic toggle="yes">PHOX2A</italic>
            </title>
            <p><bold>Gene structure.</bold> The gene contains three exons. The genomic length is approximately 5 kb [<xref ref-type="bibr" rid="cfeom.REF.nakano.2001.315">Nakano et al 2001</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cfeom" object-id="cfeom.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Four different homozygous <italic toggle="yes">PHOX2A</italic> pathogenic variants have been identified in five families with CFEOM2. Two pathogenic variants are single-base substitutions (1 missense and 1 nonsense) and two are splice-site variants [<xref ref-type="bibr" rid="cfeom.REF.nakano.2001.315">Nakano et al 2001</xref>, <xref ref-type="bibr" rid="cfeom.REF.yazdani.2003.861">Yazdani et al 2003</xref>].</p>
            <p><bold>Normal gene product.</bold> The gene product is a transcription factor protein containing a homeodomain and brachyury-like motif. See <xref ref-type="sec" rid="cfeom.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>.</p>
            <p><bold>Abnormal gene product.</bold> It is predicted that most pathogenic variants in <italic toggle="yes">PHOX2A</italic> lead to the truncation of the protein resulting in complete loss of protein function [<xref ref-type="bibr" rid="cfeom.REF.nakano.2001.315">Nakano et al 2001</xref>, <xref ref-type="bibr" rid="cfeom.REF.bosley.2006.2363">Bosley et al 2006</xref>]. It is predicted that CFEOM2 results from aberrant development of the motor nuclei [<xref ref-type="bibr" rid="cfeom.REF.nakano.2001.315">Nakano et al 2001</xref>].</p>
            <p><xref ref-type="bibr" rid="cfeom.REF.morin.1997.411">Morin et al [1997]</xref> demonstrated that <italic toggle="yes">Phox2a</italic>
<sup>-/-</sup> mice completely lacked a locus coeruleus, the main noradrenergic center of the brain. Furthermore, parasympathetic ganglia in the head are missing, and the superior cervical ganglion, as well as cranial sensory ganglia that normally express <italic toggle="yes">Phox2a</italic>, are severely affected. <xref ref-type="bibr" rid="cfeom.REF.pattyn.1997.4065">Pattyn et al [1997]</xref> demonstrated that these mice also completely lack oculomotor and trochlear motor neurons.</p>
          </sec>
          <sec id="cfeom.TUBB3">
            <title>
              <italic toggle="yes">TUBB3</italic>
            </title>
            <p><bold>Gene structure.</bold> The normal cDNA (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_006086.3">NM_006086.3</ext-link>, transcript variant 1) comprises 1794 bp in four exons and encodes 450 amino acids. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cfeom" object-id="cfeom.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Ten heterozygous pathogenic missense variants causative of CFEOM3A alter eight amino acids in exons 3 and 4 and occur recurrently [<xref ref-type="bibr" rid="cfeom.REF.tischfield.2010.74">Tischfield et al 2010</xref>, <xref ref-type="bibr" rid="cfeom.REF.whitman.2016.297">Whitman et al 2016</xref>]. Thirty-two percent of 34 reported probands have the pathogenic variant c.784C&#x0003e;T (p.Arg262Cys). CFEOM1B is most frequently caused by the missense variants c.784C&#x0003e;T (p.Arg262Cys) or c.1249G&#x0003e;A (p.Asp417Asn).</p>
            <table-wrap id="cfeom.T.selected_tubb3_pathogenic_varian" orientation="portrait" position="anchor">
              <label>Table 4. </label>
              <caption>
                <p>Selected <italic toggle="yes">TUBB3</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.185G&#x0003e;A</td>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg62Gln</td>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_3" rowspan="10" valign="middle" align="left" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_006086.3">NM_006086.3</ext-link>
<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_006077.2">NP_006077.2</ext-link></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.211G&#x0003e;A</td>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly91Arg</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.292G&#x0003e;A</td>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly98Ser</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.784C&#x0003e;T</td>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg262Cys</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.785G&#x0003e;A</td>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg262His</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.904G&#x0003e;A</td>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala302Thr</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1138C&#x0003e;T</td>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg380Cys</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1228G&#x0003e;A</td>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu410Lys</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1249G&#x0003e;A</td>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asp417Asn</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1249G&#x0003e;C</td>
                    <td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asp417His</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> This gene encodes a class III member of the beta tubulin protein family. Tubulin is the major constituent of microtubules. The TUBB3 protein is expressed in neurons and thought to be involved in neurogenesis and in axon guidance and maintenance.</p>
            <p><bold>Abnormal gene product.</bold> Multiple clinical findings and the recurrence of <italic toggle="yes">TUBB3</italic> pathogenic variants suggest that the pathogenic variants underlying CFEOM3 primarily alter microtubule function in a dominant fashion [<xref ref-type="bibr" rid="cfeom.REF.tischfield.2010.74">Tischfield et al 2010</xref>]. CFEOM-causing pathogenic vairants have been associated with increased microtubule stability [<xref ref-type="bibr" rid="cfeom.REF.tischfield.2010.74">Tischfield et al 2010</xref>, <xref ref-type="bibr" rid="cfeom.REF.tischfield.2011.286">Tischfield et al 2011</xref>].</p>
          </sec>
          <sec id="cfeom.TUBB2B">
            <title>
              <italic toggle="yes">TUBB2B</italic>
            </title>
            <p><bold>Gene structure.</bold> The normal cDNA comprises 2019 bp in four exons and encodes 445 amino acids. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cfeom" object-id="cfeom.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Seven heterozygous variants are associated with polymicrogyria. One heterozygous missense variant, p.Glu421Lys, is associated with CFEOM3 with polymicrogyria.</p>
            <table-wrap id="cfeom.T.tubb2b_pathogenic_variants_discu" orientation="portrait" position="anchor">
              <label>Table 5. </label>
              <caption>
                <p><italic toggle="yes">TUBB2B</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_cfeom.T.tubb2b_pathogenic_variants_discu_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_cfeom.T.tubb2b_pathogenic_variants_discu_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_cfeom.T.tubb2b_pathogenic_variants_discu_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_cfeom.T.tubb2b_pathogenic_variants_discu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1261G&#x0003e;A</td>
                    <td headers="hd_h_cfeom.T.tubb2b_pathogenic_variants_discu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu421Lys</td>
                    <td headers="hd_h_cfeom.T.tubb2b_pathogenic_variants_discu_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_006086.3">NM_178012.4</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_821080.1">NP_821080.1</ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> The 445-amino acid protein has an N-terminal domain, an intermediate domain, and a C-terminal domain. This gene encodes a class II member of the beta tubulin protein family, beta-tubulin isotype IIB (TUBB2B). Tubulin is the major constituent of microtubules. The TUBB2B protein is expressed in neurons and glia in the central and peripheral nervous system.</p>
            <p>Several pathogenic variants in humans lead to polymicrogyria, and are associated with decreased levels of TUBB2B protein. The p.Glu421Lys pathogenic variant, which is associated with CFEOM3 with polymicrogyria, causes increased microtubule stability in yeast and disrupts kinesin binding sites [<xref ref-type="bibr" rid="cfeom.REF.cederquist.2012.5484">Cederquist et al 2012</xref>].</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants associated with polymicrogyria fold and incorporate into microtubules poorly, and the phenotype may therefore be caused by haploinsufficiency. The pathogenic variant associated with CFEOM3 with polymicrogyria reduces the formation of alpha-beta heterodimers, and disrupts microtubule dynamics [<xref ref-type="bibr" rid="cfeom.REF.cederquist.2012.5484">Cederquist et al 2012</xref>].</p>
          </sec>
        </sec>
      </sec>
      <sec id="cfeom.References">
        <title>References</title>
        <sec id="cfeom.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="cfeom.Literature_Cited.reflist0">
            <ref id="cfeom.REF.albaradie.2002.1195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al-Baradie</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St Hilaire</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McIntosh</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martonyi</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okumura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okihiro</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family.</article-title>
                <source>Am J Hum Genet</source>
                <volume>71</volume>
                <fpage>1195</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12395297</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.ali.2004.247">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venkatesh</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ragunath</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutation analysis of the KIF21A gene in an Indian family with CFEOM1: implication of CpG methylation for most frequent mutations.</article-title>
                <source>Ophthalmic Genet</source>
                <volume>25</volume>
                <fpage>247</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">15621877</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.ali.2014.368">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ali</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xing</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anwar</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itani</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weakley</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gong</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mootha</surname>
                    <given-names>VV</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>A novel de novo KIF21A mutation in a patient with congenital fibrosis of the extraocular muscles and M&#x000f6;bius syndrome.</article-title>
                <source>Mol Vis.</source>
                <volume>20</volume>
                <fpage>368</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">24715754</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.aubourg.2005.253">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aubourg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krahn</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nguyen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forzano</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boccaccio</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delague</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Sandre-Giovannoli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pouget</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Depetris</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mattei</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philip</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Assignment of a new congenital fibrosis of extraocular muscles type 3 (CFEOM3) locus, FEOM4, based on a balanced translocation t(2;13) (q37.3;q12.11) and identification of candidate genes.</article-title>
                <source>J Med Genet</source>
                <volume>42</volume>
                <fpage>253</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15744040</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.bahibuisson.2014.1676">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bahi-Buisson</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poirier</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fourniol</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saillour</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valence</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebrun</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hully</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bianco</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boddaert</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elie</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lascelles</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Souville</surname>
                    <given-names>I</given-names>
                  </name>
                  <collab>LIS-Tubulinopathies Consortium</collab>
                </person-group>
                <article-title>Beldjord C, Chelly J. The wide spectrum of tubulinopathies: what are the key features for the diagnosis?</article-title>
                <source>Brain.</source>
                <year>2014</year>
                <volume>137</volume>
                <fpage>1676</fpage>
                <lpage>700</lpage>
                <pub-id pub-id-type="pmid">24860126</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.balasubramanian.2015.e473">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Balasubramanian</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chew</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacKinnon</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Expanding the phenotypic spectrum and variability of endocrine abnormalities associated with TUBB3 E410K syndrome.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>100</volume>
                <fpage>E473</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">25559402</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.bosley.2006.2363">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bosley</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oystreck</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robertson</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>al Awad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abu-Amero</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Neurological features of congenital fibrosis of the extraocular muscles type 2 with mutations in PHOX2A.</article-title>
                <source>Brain</source>
                <volume>129</volume>
                <fpage>2363</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">16815872</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.bosley.2005.1196">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bosley</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salih</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oystreck</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abu-Amero</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>al Zayed</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>al Dhalaan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kansu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stigsby</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Neurologic features of horizontal gaze palsy and progressive scoliosis with mutations in ROBO3.</article-title>
                <source>Neurology</source>
                <volume>64</volume>
                <fpage>1196</fpage>
                <lpage>203</lpage>
                <pub-id pub-id-type="pmid">15824346</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.brodsky.1998.717">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brodsky</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Hereditary external ophthalmoplegia synergistic divergence, jaw winking, and oculocutaneous hypopigmentation: a congenital fibrosis syndrome caused by deficient innervation to extraocular muscles.</article-title>
                <source>Ophthalmology</source>
                <volume>105</volume>
                <fpage>717</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">9544647</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.cederquist.2012.5484">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cederquist</surname>
                    <given-names>GY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luchniak</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tischfield</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peeva</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menezes</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chew</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jamieson</surname>
                    <given-names>RV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomes</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flaherty</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grant</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>ML</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>An inherited TUBB2B mutation alters a kinesin-binding site and causes polymicrogyria, CFEOM and axon dysinnervation.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>21</volume>
                <fpage>5484</fpage>
                <lpage>99</lpage>
                <pub-id pub-id-type="pmid">23001566</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.chan.2007.26">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dragan</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fredrick</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armstrong</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyons</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geraghty</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunter</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yazdani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traboulsi</surname>
                    <given-names>EI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pott</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutowski</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanisch</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koc</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schnall</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Three novel mutations in KIF21A highlight the importance of the third coiled-coil stalk domain in the etiology of CFEOM1.</article-title>
                <source>BMC Genet.</source>
                <volume>8</volume>
                <fpage>26</fpage>
                <pub-id pub-id-type="pmid">17511870</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.chan.2006.e11">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traboulsi</surname>
                    <given-names>EI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arthur</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Horizontal gaze palsy with progressive scoliosis can result from compound heterozygous mutations in ROBO3.</article-title>
                <source>J Med Genet</source>
                <volume>43</volume>
                <fpage>e11</fpage>
                <pub-id pub-id-type="pmid">16525029</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.cheng.2014.334">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desai</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miranda</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duncan</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qiu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nugent</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolpak</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drokhlyansky</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delisle</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wei</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Propst</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reck-Peterson</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fritzsch</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Human CFEOM1 mutations attenuate KIF21A autoinhibition and cause oculomotor axon stalling.</article-title>
                <source>Neuron</source>
                <volume>82</volume>
                <fpage>334</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">24656932</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.chew.2013.522">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chew</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balasubramanian</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webb</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacKinnon</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oystreck</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rankin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crawford</surname>
                    <given-names>TO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geraghty</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pomeroy</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crowley</surname>
                    <given-names>WF</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Jabs</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunter</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grant</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <article-title>A novel syndrome caused by the E410K amino acid substitution in the neuronal &#x003b2;-tubulin isotype 3.</article-title>
                <source>Brain.</source>
                <year>2013</year>
                <volume>136</volume>
                <fpage>522</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">23378218</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.demer.2005.530">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Demer</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Magnetic resonance imaging evidence for widespread orbital dysinnervation in congenital fibrosis of extraocular muscles due to mutations in KIF21A.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <volume>46</volume>
                <fpage>530</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15671279</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.demer.2010.4600">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Demer</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tischfield</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Evidence of an asymmetrical endophenotype in congenital fibrosis of extraocular muscles type 3 resulting from TUBB3 mutations.</article-title>
                <source>Invest Ophthalmol Vis Sci.</source>
                <volume>51</volume>
                <fpage>4600</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">20393110</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.desai.2012.180">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Desai</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velo</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Overman</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Spatiotemporal expression pattern of KIF21A during normal embryonic development and in congenital fibrosis of the extraocular muscles type 1 (CFEOM1).</article-title>
                <source>Gene Expr Patterns</source>
                <volume>12</volume>
                <fpage>180</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22465342</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.doherty.1999.1687">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Doherty</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macy</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dykeman</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melanson</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>CFEOM3: a new extraocular congenital fibrosis syndrome that maps to 16q24.2-q24.3.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <volume>40</volume>
                <fpage>1687</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">10393037</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.elgohary.2005.319">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Elgohary</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradshaw</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmad</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Anterior uveitis and congenital fibrosis of the extraocular muscles in a patient with Noonan syndrome.</article-title>
                <source>J Postgrad Med</source>
                <volume>51</volume>
                <fpage>319</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">16388177</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.engle.1997.314">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goumnerov</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKeown</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schatz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johns</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porter</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beggs</surname>
                    <given-names>AH</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles.</article-title>
                <source>Ann Neurol</source>
                <volume>41</volume>
                <fpage>314</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">9066352</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.falletbianco.2014.69">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fallet-Bianco</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laquerri&#x000e8;re</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poirier</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Razavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guimiot</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dias</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loeuillet</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lascelles</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beldjord</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carion</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toussaint</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Revencu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Addor</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lhermitte</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzales</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinovich</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bessieres</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marcy-Bonni&#x000e8;re</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jossic</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marcorelles</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loget</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chelly</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahi-Buisson</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in tubulin genes are frequent causes of various foetal malformations of cortical development including microlissencephaly.</article-title>
                <source>Acta Neuropathol Commun.</source>
                <year>2014</year>
                <volume>2</volume>
                <fpage>69</fpage>
                <pub-id pub-id-type="pmid">25059107</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.flaherty.2001.1313">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Flaherty</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grattan-Smith</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinberg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jamieson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Congenital fibrosis of the extraocular muscles associated with cortical dysplasia and maldevelopment of the basal ganglia.</article-title>
                <source>Ophthalmology.</source>
                <volume>108</volume>
                <fpage>1313</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">11425694</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.guo.1999.555">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brush</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teraoka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goddard</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullins</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenthal</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Development of noradrenergic neurons in the zebrafish hindbrain requires BMP, FGF8, and the homeodomain protein soulless/Phox2a.</article-title>
                <source>Neuron</source>
                <volume>24</volume>
                <fpage>555</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">10595509</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.gutowski.2003.573">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gutowski</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosley</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>110th ENMC International Workshop: the congenital cranial dysinnervation disorders (CCDDs). Naarden, The Netherlands, 25-27 October, 2002.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>13</volume>
                <fpage>573</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12921795</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.harissidagher.2004.540">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harissi-Dagher</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dagher</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aroichane</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Congenital fibrosis of the extraocular muscles with brain-stem abnormalities: a novel finding.</article-title>
                <source>Can J Ophthalmol</source>
                <volume>39</volume>
                <fpage>540</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15491041</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.holve.2003.169">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holve</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoyme</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tarby</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnstone</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erickson</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clericuzio</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cunniff</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Athabascan brainstem dysgenesis syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>120A</volume>
                <fpage>169</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">12833395</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.iannaccone.2002.175">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Iannaccone</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McIntosh</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciccarelli</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baldi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mutolo</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tedesco</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Familial unilateral Brown syndrome.</article-title>
                <source>Ophthalmic Genet</source>
                <volume>23</volume>
                <fpage>175</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">12324876</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.jaglin.2009.746">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jaglin</surname>
                    <given-names>XH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poirier</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saillour</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buhler</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tian</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahi-Buisson</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fallet-Bianco</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phan-Dinh-Tuy</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kong</surname>
                    <given-names>XP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bomont</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castelnau-Ptakhine</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loget</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kossorotoff</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snoeck</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plessis</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parent</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beldjord</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cardoso</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Represa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flint</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keays</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cowan</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chelly</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Mutations in the beta-tubulin gene TUBB2B result in asymmetrical polymicrogyria.</article-title>
                <source>Nat Genet.</source>
                <volume>41</volume>
                <fpage>746</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">19465910</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.jen.2004.1509">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosley</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carr</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rub</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shattuck</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salamon</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kudo</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ou</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salih</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kansu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Dhalaan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Zayed</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stigsby</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plaitakis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dretakis</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gottlob</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pieh</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traboulsi</surname>
                    <given-names>EI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demer</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karim</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alger</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geschwind</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deller</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sicotte</surname>
                    <given-names>NL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutations in a human ROBO gene disrupt hindbrain axon pathway crossing and morphogenesis.</article-title>
                <source>Science</source>
                <volume>304</volume>
                <fpage>1509</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">15105459</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.ka_ar_bayram.2015.743">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ka&#x000e7;ar Bayram</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Per</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quon</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canpolat</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>&#x000dc;lgen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Do&#x0011f;an</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gumus</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumandas</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayram</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bilguvar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>&#x000c7;a&#x0011f;layan</surname>
                    <given-names>AO</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>A rare case of congenital fibrosis of extraocular muscle type 1A due to KIF21A mutation with Marcus Gunn jaw-winking phenomenon.</article-title>
                <source>Eur J Paediatr Neurol.</source>
                <volume>19</volume>
                <fpage>743</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">26190014</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.karadeniz.2009.e570">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Karadeniz</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erkek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taner</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Unexpected clinical involvement of hereditary total leuconychia with congenital fibrosis of the extraocular muscles in three generations.</article-title>
                <source>Clin Exp Dermatol.</source>
                <volume>34</volume>
                <fpage>e570</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">19489868</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.katsetos.2003.851">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Katsetos</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legido</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perentes</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000f6;rk</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Class III beta-tubulin isotype: a key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology.</article-title>
                <source>J Child Neurol.</source>
                <volume>18</volume>
                <fpage>851</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">14736079</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.khan.2010.154">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>AO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khalil</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Sharif</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Ghadhfan</surname>
                    <given-names>FE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Tassan</surname>
                    <given-names>NA</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Germline mosaicism for KIF21A mutation (p.R954L) mimicking recessive inheritance for congenital fibrosis of the extraocular muscles.</article-title>
                <source>Ophthalmology.</source>
                <volume>117</volume>
                <fpage>154</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19896199</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.khan.2011.218">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>AO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shinwari</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Omar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Sharif</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khalil</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alanazi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Amri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Tassan</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Lack of KIF21A mutations in congenital fibrosis of the extraocular muscles type I patients from consanguineous Saudi Arabian families.</article-title>
                <source>Mol Vis.</source>
                <volume>17</volume>
                <fpage>218</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">21264235</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.kim.2005.728">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwang</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Hypoplastic oculomotor nerve and absent abducens nerve in congenital fibrosis syndrome and synergistic divergence with magnetic resonance imaging.</article-title>
                <source>Ophthalmology</source>
                <volume>112</volume>
                <fpage>728</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">15808269</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.kohlhase.2002.2979">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kohlhase</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heinrich</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schubert</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liebers</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kispert</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laccone</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnpenny</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winter</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reardon</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Okihiro syndrome is caused by SALL4 mutations.</article-title>
                <source>Hum Mol Genet</source>
                <volume>11</volume>
                <fpage>2979</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">12393809</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.lim.2007.1601">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demer</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Abnormalities of the oculomotor nerve in congenital fibrosis of the extraocular muscles and congenital oculomotor palsy.</article-title>
                <source>Invest Ophthalmol Vis Sci.</source>
                <volume>48</volume>
                <fpage>1601</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17389489</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.lin.2005.245">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chien</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiang</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwu</surname>
                    <given-names>WL</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>KIF21A gene c.2860C&#x0003e;T mutation in congenital fibrosis of extraocular muscles type 1 and 3.</article-title>
                <source>Mol Vis</source>
                <volume>11</volume>
                <fpage>245</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15827546</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.liu.2014.15">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pan</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Maternal germline mosaicism of kinesin family member 21A (KIF21A) mutation causes complex phenotypes in a Chinese family with congenital fibrosis of the extraocular muscles.</article-title>
                <source>Mol Vis.</source>
                <volume>20</volume>
                <fpage>15</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">24426772</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.lu.2008.388">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larsson</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Novel and recurrent KIF21A mutations in congenital fibrosis of the extraocular muscles type 1 and 3.</article-title>
                <source>Arch Ophthalmol.</source>
                <volume>126</volume>
                <fpage>388</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">18332320</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.luk.2013.182">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Luk</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lo</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tong</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lam</surname>
                    <given-names>ST</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Congenital fibrosis of extraocular muscle type 1A due to KIF21A mutation: first case report from Hong Kong.</article-title>
                <source>Hong Kong Med J.</source>
                <volume>19</volume>
                <fpage>182</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">23535681</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.mackinnon.2014.1461">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>MacKinnon</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oystreck</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunter</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <article-title>Diagnostic distinctions and genetic analysis of patients diagnosed with Moebius syndrome.</article-title>
                <source>Ophthalmology</source>
                <year>2014</year>
                <volume>121</volume>
                <fpage>1461</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">24612975</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.marszalek.1999.469">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marszalek</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiner</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farlow</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chun</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldstein</surname>
                    <given-names>LS</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Novel dendritic kinesin sorting identified by different process targeting of two related kinesins: KIF21A and KIF21B.</article-title>
                <source>J Cell Biol</source>
                <volume>145</volume>
                <fpage>469</fpage>
                <lpage>79</lpage>
                <pub-id pub-id-type="pmid">10225949</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.miyake.2010.215">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miyake</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fan</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>CHN1 mutations are not a common cause of sporadic Duane's retraction syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>152A</volume>
                <fpage>215</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20034095</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.miyake.2008.839">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miyake</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chilton</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Psatha</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Law</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crosier</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindsay</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheung</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutowski</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iannaccone</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appukuttan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stout</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christiansen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciccarelli</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baldi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campioni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zenteno</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davenport</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mariani</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guthrie</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <article-title>Human CHN1 mutations hyperactivate alpha2-chimaerin and cause Duane's retraction syndrome.</article-title>
                <source>Science.</source>
                <year>2008</year>
                <volume>321</volume>
                <fpage>839</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">18653847</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.morin.1997.411">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morin</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cremer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirsch</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kapur</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goridis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunet</surname>
                    <given-names>JF</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Defects in sensory and autonomic ganglia and absence of locus coeruleus in mice deficient for the homeobox gene Phox2a.</article-title>
                <source>Neuron</source>
                <volume>18</volume>
                <fpage>411</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">9115735</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.nakano.2001.315">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fain</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sener</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selleck</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Awad</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zwaan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullaney</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosley</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Homozygous mutations in ARIX(PHOX2A) result in congenital fibrosis of the extraocular muscles type 2.</article-title>
                <source>Nat Genet</source>
                <volume>29</volume>
                <fpage>315</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">11600883</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.oegema.2015.5313">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oegema</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cushion</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phelps</surname>
                    <given-names>IG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dempsey</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullins</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dudding</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gill</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishak</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rees</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doherty</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Recognizable cerebellar dysplasia associated with mutations in multiple tubulin genes.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2015</year>
                <volume>24</volume>
                <fpage>5313</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">26130693</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.papakostas.2015.248">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Papakostas</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chodosh</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobs</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <article-title>Prosthetic replacement of the ocular surface ecosystem as treatment for ocular surface disease in patients with a history of Stevens-Johnson syndrome/toxic epidermal necrolysis.</article-title>
                <source>Ophthalmology.</source>
                <year>2015</year>
                <volume>122</volume>
                <fpage>248</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">25282251</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.pattyn.1997.4065">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pattyn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morin</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cremer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goridis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunet</surname>
                    <given-names>JF</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Expression and interactions of the two closely related homeobox genes Phox2a and Phox2b during neurogenesis.</article-title>
                <source>Development</source>
                <volume>124</volume>
                <fpage>4065</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">9374403</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.pieh.2003.546">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pieh</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gottlob</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Congenital fibrosis syndrome associated with central nervous system abnormalities.</article-title>
                <source>Graefes Arch Clin Exp Ophthalmol</source>
                <volume>241</volume>
                <fpage>546</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">12819981</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.poirier.2010.4462">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Poirier</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saillour</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahi-Buisson</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaglin</surname>
                    <given-names>XH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fallet-Bianco</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nabbout</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castelnau-Ptakhine</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roubertie</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attie-Bitach</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desguerre</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genevieve</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barnerias</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keren</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebrun</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boddaert</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Encha-Razavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chelly</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Mutations in the neuronal &#x000df;-tubulin subunit TUBB3 result in malformation of cortical development and neuronal migration defects.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>19</volume>
                <fpage>4462</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">20829227</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.reck.1998.676">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reck</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manners</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hatchwell</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Phenotypic heterogeneity may occur in congenital fibrosis of the extraocular muscles.</article-title>
                <source>Br J Ophthalmol</source>
                <volume>82</volume>
                <fpage>676</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9797671</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.rudolph.2009.667">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rudolph</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nentwich</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellebrand</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollack</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gordes</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bau</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kampik</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meindl</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>KIF21A variant R954W in familial or sporadic cases of CFEOM1.</article-title>
                <source>Eur J Ophthalmol.</source>
                <volume>19</volume>
                <fpage>667</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">19551685</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.shimizu.2005.443">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okinaga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maruo</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Recurrent mutation of the KIF21A gene in Japanese patients with congenital fibrosis of the extraocular muscles.</article-title>
                <source>Jpn J Ophthalmol</source>
                <volume>49</volume>
                <fpage>443</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16365788</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.shinwari.2015.147">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shinwari</surname>
                    <given-names>JMA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Awad</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shinwari</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alaiya</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alanazi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tahir</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poizat</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Tassan</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Recessive mutations in COL25A1 are a cause of congenital cranial dysinnervation disorder.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>96</volume>
                <fpage>147</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">25500261</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.tiab.2004.241">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tiab</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>d'Alleves Manzi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borruat</surname>
                    <given-names>FX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munier</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schorderet</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutation analysis of KIF21A in congenital fibrosis of the extraocular muscles (CFEOM) patients.</article-title>
                <source>Ophthalmic Genet</source>
                <volume>25</volume>
                <fpage>241</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15621876</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.tischfield.2010.74">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tischfield</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baris</surname>
                    <given-names>HN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudolph</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Maldergem</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demer</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robertson</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackey</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruddle</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gottlob</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pieh</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traboulsi</surname>
                    <given-names>EI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pomeroy</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunter</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soul</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newlin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabol</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doherty</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Uzc&#x000e1;tegui</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Uzc&#x000e1;tegui</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sener</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wabbels</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellebrand</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meitinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Berardinis</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiavi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pastore-Trossello</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koc</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levin</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geraghty</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Descartes</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flaherty</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jamieson</surname>
                    <given-names>RV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000f8;ller</surname>
                    <given-names>HU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meuthen</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callen</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerwin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindsay</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meindl</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>ML</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Pellman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance.</article-title>
                <source>Cell.</source>
                <volume>140</volume>
                <fpage>74</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">20074521</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.tischfield.2005.1035">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tischfield</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosley</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salih</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alorainy</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sener</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nester</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oystreck</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erickson</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Homozygous HOXA1 mutations disrupt human brainstem, inner ear, cardiovascular and cognitive development.</article-title>
                <source>Nat Genet</source>
                <volume>37</volume>
                <fpage>1035</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16155570</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.tischfield.2011.286">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tischfield</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cederquist</surname>
                    <given-names>GY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>ML</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Phenotypic spectrum of the tubulin-related disorders and functional implications of disease-causing mutations.</article-title>
                <source>Curr Opin Genet Dev</source>
                <volume>21</volume>
                <fpage>286</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">21292473</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.traboulsi.2004.237">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Traboulsi</surname>
                    <given-names>EI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in KIF21A are responsible for CFEOM1 worldwide.</article-title>
                <source>Ophthalmic Genet.</source>
                <year>2004</year>
                <volume>25</volume>
                <fpage>237</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15621875</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.tukel.2005.408">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tukel</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uzumcu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gezer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kayserili</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuksel-Apak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uyguner</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gultekin</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennies</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nurnberg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desnick</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wollnik</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>A new syndrome, congenital extraocular muscle fibrosis with ulnar hand anomalies, maps to chromosome 21qter.</article-title>
                <source>J Med Genet</source>
                <volume>42</volume>
                <fpage>408</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">15863670</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.van_der_vaart.2013.145">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Vaart</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Riel</surname>
                    <given-names>WE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doodhi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kevenaar</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katrukha</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gumy</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouchet</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grigoriev</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spangler</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wulf</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lansbergen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Battum</surname>
                    <given-names>EY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasterkamp</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mimori-Kiyosue</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demmers</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olieric</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maly</surname>
                    <given-names>IV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoogenraad</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akhmanova</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>CFEOM1-associated kinesin KIF21A is a cortical microtubule growth inhibitor.</article-title>
                <source>Dev Cell.</source>
                <volume>27</volume>
                <fpage>145</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">24120883</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.wabbels.2004.216">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wabbels</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlhase</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>No evidence of SALL4-mutations in isolated sporadic duane retraction "syndrome" (DURS).</article-title>
                <source>Am J Med Genet A.</source>
                <volume>131</volume>
                <fpage>216</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15386473</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.wang.2011.973">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>Q.</given-names>
                  </name>
                </person-group>
                <article-title>KIF21A novel deletion and recurrent mutation in patients with congenital fibrosis of the extraocular muscles-1.</article-title>
                <source>Int J Mol Med.</source>
                <year>2011</year>
                <volume>28</volume>
                <fpage>973</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21805025</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.wang.1998.517">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zwaan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullaney</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jabak</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Awad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beggs</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <article-title>Congenital fibrosis of the extraocular muscles type 2, an inherited exotropic strabismus fixus, maps to distal 11q13.</article-title>
                <source>Am J Hum Genet.</source>
                <year>1998</year>
                <volume>63</volume>
                <fpage>517</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">9683611</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.whitman.2016.297">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Whitman</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tischfield</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stasheff</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brancati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ortiz-Gonzalez</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nuovo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garaci</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacKinnon</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunter</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grant</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <article-title>Two unique TUBB3 mutations cause both CFEOM3 and malformations of cortical development.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2016</year>
                <volume>170A</volume>
                <fpage>297</fpage>
                <lpage>305</lpage>
                <pub-id pub-id-type="pmid">26639658</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.wu.2009.971">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cha</surname>
                    <given-names>YF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xing</surname>
                    <given-names>YQ</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Magnetic resonance imaging features in two Chinese family with congenital fibrosis of extraocular muscles.</article-title>
                <source>Zhonghua Yan Ke Za Zhi.</source>
                <volume>45</volume>
                <fpage>971</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20137413</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.yamada.2003.318">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKeown</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Berardinis</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loewenstein</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lazar</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Keefe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Letson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>London</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruttum</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Monte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uyama</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houtman</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carlow</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krawiecki</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoffner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogel</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katowitz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldstein</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levin</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sener</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozturk</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akarsu</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brodsky</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanisch</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruse</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zubcov</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robb</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roggenkaemper</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gottlob</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kowal</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battu</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traboulsi</surname>
                    <given-names>EI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franceschini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newlin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demer</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1).</article-title>
                <source>Nat Genet</source>
                <volume>35</volume>
                <fpage>318</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">14595441</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.yamada.2004.2218">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosley</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sener</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zwaan</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullaney</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozturk</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akarsu</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabol</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demer</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sullivan</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gottlob</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roggenkaemper</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackey</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Uzcategui</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uzcategui</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Zeev</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traboulsi</surname>
                    <given-names>EI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Berardinis</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gagliardi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Awasthi-Patney</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogel</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzo</surname>
                    <given-names>JF</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Identification of KIF21A mutations as a rare cause of congenital fibrosis of the extraocular muscles type 3 (CFEOM3).</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <volume>45</volume>
                <fpage>2218</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">15223798</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.yamada.2005.1254">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunter</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>A novel KIF21A mutation in a patient with congenital fibrosis of the extraocular muscles and Marcus Gunn jaw-winking phenomenon.</article-title>
                <source>Arch Ophthalmol</source>
                <volume>123</volume>
                <fpage>1254</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16157808</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.yang.2010.2062">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tong</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kong</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kong</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fan</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ning</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>KIF21A mutations in two Chinese families with congenital fibrosis of the extraocular muscles (CFEOM).</article-title>
                <source>Mol Vis.</source>
                <volume>16</volume>
                <fpage>2062</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">21042561</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.yazdani.2003.861">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yazdani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbaszadegan</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Khayer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yazdani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghodsi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traboulsi</surname>
                    <given-names>EI</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A novel PHOX2A/ARIX mutation in an Iranian family with congenital fibrosis of extraocular muscles type 2 (CFEOM2).</article-title>
                <source>Am J Ophthalmol</source>
                <volume>136</volume>
                <fpage>861</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">14597037</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.yazdani.2004.1035">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yazdani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traboulsi</surname>
                    <given-names>EI</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Classification and surgical management of patients with familial and sporadic forms of congenital fibrosis of the extraocular muscles.</article-title>
                <source>Ophthalmology</source>
                <volume>111</volume>
                <fpage>1035</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">15121385</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.ying.2013.63">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ying</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Han</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hao</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Inherited KIF21A and PAX6 gene mutations in a boy with congenital fibrosis of extraocular muscles and aniridia.</article-title>
                <source>BMC Med Genet.</source>
                <volume>14</volume>
                <fpage>63</fpage>
                <pub-id pub-id-type="pmid">23799907</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="cfeom.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="cfeom.Suggested_Reading.reflist0">
            <ref id="cfeom.REF.engle.2002.3">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McIntosh</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Keefe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Letson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>London</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruttum</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Berardinis</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>CFEOM1, the classic familial form of congenital fibrosis of the extraocular muscles, is genetically heterogeneous but does not result from mutations in ARIX.</article-title>
                <source>BMC Genet.</source>
                <volume>3</volume>
                <fpage>3</fpage>
                <pub-id pub-id-type="pmid">11882252</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.mackey.2002.510">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mackey</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillies</surname>
                    <given-names>WE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Day</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Congenital fibrosis of the vertically acting extraocular muscles maps to the FEOM3 locus.</article-title>
                <source>Hum Genet.</source>
                <volume>110</volume>
                <fpage>510</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">12073023</pub-id>
              </element-citation>
            </ref>
            <ref id="cfeom.REF.traboulsi.2004.373">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Traboulsi</surname>
                    <given-names>EI</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Congenital abnormalities of cranial nerve development: overview, molecular mechanisms, and further evidence of heterogeneity and complexity of syndromes with congenital limitation of eye movements.</article-title>
                <source>Trans Am Ophthalmol Soc.</source>
                <volume>102</volume>
                <fpage>373</fpage>
                <lpage>89</lpage>
                <pub-id pub-id-type="pmid">15747768</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="cfeom.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="cfeom.Author_Notes">
          <title>Author Notes</title>
          <p>Dr. Engle&#x02019;s Web sites:<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.hhmi.org/scientists/elizabeth-c-engle">www.hhmi.org</ext-link><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://dms.hms.harvard.edu/neuroscience/fac/Engle.php">dms.hms.harvard.edu</ext-link></p>
          <p><bold>Engle Laboratory</bold>
Division of Genetics, Children's Hospital Boston</p>
        </sec>
        <sec id="cfeom.Author_History">
          <title>Author History</title>
          <p>Caroline Andrews, MSc; Howard Hughes Medical Institute (2004-2016) Jigar Desai, PhD; Children&#x02019;s Hospital Boston (2006-2011) Elizabeth C Engle, MD (2004-present) David G Hunter, MD, PhD (2006-present) Mary Whitman, MD, PhD (2016-present)Koki Yamada, MD, PhD; Children's Hospital Boston (2004-2006)</p>
        </sec>
        <sec id="cfeom.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>14 January 2016 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>29 December 2011 (cd) Revision: sequence analysis available clinically for <italic toggle="yes">PHOX2A</italic></p>
            </list-item>
            <list-item>
              <p>28 July 2011 (cd) Revision: sequence analysis available clinically for entire coding region of <italic toggle="yes">KIF21A</italic></p>
            </list-item>
            <list-item>
              <p>21 April 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>19 December 2006 (cd) Revision: prenatal diagnosis available for CFEOM1</p>
            </list-item>
            <list-item>
              <p>22 September 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>27 April 2004 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>7 January 2004 (ee) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
